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Apolipoprotein E (apoE), with three common isoforms apoE2, apoE3 and apoE4, 
plays important role in atherosclerosis. One of the anti-atherogenic properties of 
apoE3 has been attributed to its ability to inhibit cell proliferation. And the 
anti-proliferative effects of apoE3 were accompanied by a decrease in ERKl/2 
mitogen-activated protein kinase (MAPK) activity. Most of the previous studies 
focused on apoE3. In this study, it is hypothesized that endogenously expressed apoE 
proteins exert isoform-specific effects on cell proliferation via similar molecular 
mechanisms. F i l l rat embryonic fibroblasts without native apoE expression were 
transacted with control or human apoE isoform-encoding plasmids. Expression of 
apoE was detected by western blot and quantified by enzyme-linked immunosorbent 
assay. Stable cell lines with similar apoE expression levels were used for experiments. 
Direct cell count, H-thymidine incorporation, and flow cytometry analyses were 
performed to characterize cell proliferation. Western blot and real time polymerase 
chain reaction were conducted to study the cell proliferation-related signaling 
V 
pathways. Expression of apoE isoforms showed inhibitory effects on cell 
proliferation with apoE3 being the most potent isoform. The anti-proliferative effects 
of all three isoforms were associated with a lengthened Go/Gi phase of the cell cycle. 




MAPK. ApoE3 and apoE4 inhibited ERKl/2 to greater extent than apoE2 while 
apoE4 showed the strongest inactivation on ERK5. A down-regulation of 
transcriptional activities of c-Jun also accompanied apoE expression, with apoE4 
giving the most potent effect. In addition, apoE expression increased the mRNA level 
of cyclin A and p21, but was associated with a decreased cyclin D1 mRNA. ApoE4 
significantly increased the mRNA of cyclin A while apoE3 significantly decreased 
that of cyclin Dl . Taken together, endogenous apoE expression inhibits cell 
proliferation in an isoform-specific manner, with apoE3 being the most potent 
isoform as compared to apoE2 and apoE4. The down-regulation of ERKl/2 and 
ERK5 MAPK may partially explain the anti-proliferative effects of apoE but is 
insufficient to explain the isoform-specific effects. 
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這三個同種型的表達能減低ERK1/2及ERK5 MAPK的激活作用’ ApoE3和 





Abstract in Chinese 摘要 
的表達’如它可增加細胞週期蛋白A (Cyclin A)及p21和減少細胞週期蛋白 
Dl(CyclinDl)的信使核糖核酸（mRNA)的水平。其中，ApoE4可顯著地增加 
Cyclin A的m R N A 7jc平及ApoE3可顯著地減少Cydin D1 mRNA的水平。 
總括而言’內源性表達的ApoE能夠抑制細胞增殖’而此乃同種型特選的作 
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Chapter 1: Introduction 
1 Introduction 
1.1 Apolipoprotein and Lipoprotein Metabolism 
Plasma lipids, including fatty acids, triglycerides, phospholipids and cholesterol, 
are relatively insoluble in water; they are carried in body fluids as soluble protein 
complexes known as lipoproteins. The proteins surrounding the insoluble core of 
lipids are referred to as apolipoproteins. Apart from maintaining the structural 
integrity of lipoprotein, apolipoproteins also play important roles in lipid 
metabolism by acting as cofactors of enzymes and ligands for lipoprotein 
receptors. Table 1.1 summarizes different classes of lipoproteins together with 
their associated lipids and apolipoproteins. The target protein of the present study 
is apolipoprotein E (apoE), one of the apolipoproteins associated with 
chylomicrons, very low density lipoproteins (VLDL) and high density 
lipoproteins (HDL). -
Table 1.1: Compositions of the main lipoprotein particles. 
Lipoprotein* Major Lipid Apolipoprotein 
Chylomicrons Triglycerides A, B, C, E 
VLDL Triglycerides and Cholesterol B, C, E 
LDL Cholesterol B 
HDL Cholesterol and Phospholipids A, C, E 
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1.2 Molecular Information of Apolipoprotein E 
The APOE gene mapped to the long arm of chromosome 19 at locus 13.2 in the 
human genome is approximately 3.7 kilobases in length and contains 3 introns 
and 4 exons with an intronic to exonic DNA ratio approximately 2:1 (Das et ai, 
1985). An examination of the nucleotide sequence of the APOE gene reveals 
eight 66-base pair tandem repeats in exon 4 (Das et ai, 1985). The consensus 
sequence obtained from the 8 tandem repeats is translated into an amino acid 
sequence which is deduced to be an amphipathic region, an important 
characteristic of apolipoprotein structure and lipid carrying protein (Das et ai, 
1985). On the same chromosome, the APOE gene forms a gene cluster with 
genes coding for other apolipoproteins, apoC-II, apoC-I and its pseudogene (Das 
et ai, 1985; Paik et ai, 1985). Figure 1.1 shows a schematic diagram of the 
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ApoE2 gac gtg tgc ggc cgc ctg ctg cag aag tgc ctg gca 
ApoE3 gac gtg tgc ggc cgc ctg ctg cag aag cgc ctg gca 
ApoE4 gac gtg cgc ggc cgc ctg ctg cag aag cgc ctg gca 
Residue 112 158 
Figure 1.1: A schematic diagram of apoiipoprotein gene clusters on human 
chromosome 19. The open boxes represent gene fragments for different 
apolipoproteins while the shaded boxes represent the 4 exons of the APOE gene. 
Partial sequences of apoE cDNA coding for the polymorphic amino acid residues 
112 and 158 are also shown. 
The transcription of APOE gene is initiated by a promoter showing a consensus 
sequence TATAATT 33 base pairs upstream of the transcriptional initiation site 
(Das et al, 1985). The messenger RNA (mRNA) of APOE is 1,163 nucleotides in 
length and encodes for a precursor protein of 317 residues, in which the 18 
amino-terminal amino acids serve as a signal peptide and are cotranslationally 
removed (McLean et al, 1984). The mature protein is secreted as a 299-amino 
acid peptide with a molecular mass of approximately 34 kDa. In fact, the protein 
was first discovered as a major protein component of human plasma VLDL in 
‘ 1973 by Shore and Shore. The apoE protein is originally termed as "arginine-rich 
protein" due to the relatively high arginine content when compared to other 
apolipoproteins (Shore & Shore, 1973) and is normally present at 5 mg/dL in 
« 
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plasma (Mahley, 1988). 
1.3 Protein Structure of Apolipoprotein E 
Enzymatic hydrolysis of apoE protein with thrombin results in the generation of 
two major fragments: the 22 kDa amino-terminal fragment and the 10 kDa 
carboxyl-terminal fragment (Mahley, 1988; Weisgraber, et ai, 1983). These two 
structural domains actually represent two functional domains; residues extending 
from 1 to 191 constitute receptor-binding as well as heparin sulfate proteoglycan 
(HSPG)-binding regions while residues from 225 to 299 constitute the 
lipid-binding domain (Mahley, 1988; Mahley & Rail, 2000). 
Residues 140 - 150 within the amino-terminal domain are enriched with basic 
residues, arginine and lysine, and are essential for both receptor and heparin 
binding (Mahley & Rail, 2000). Tfie positively charged residues are responsible 
for ionic interaction with the negatively charged residues, aspartate and glutamate, 
on the receptor surface as well as N- and 0-sulfo groups on heparin (Libeu et ai, 
2001; Nimpf & Schneider, 2000). On the other hand, amphipathic a-helices, 
characterized by one face composed of apolar residues and the other of polar 
I 
residues, formed in several regions of the carboxyl terminus encompass the 
lipid-binding site of the apoE protein (Mahley, 1988; Mahley & Rail，2000). 
4 
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1.4 Polymorphism of Apolipoprotein E 
The apoE protein is polymorphic, exhibiting multiple isoforms as detected by 
isoelectric focusing (Utermann et ai, 1977) and two-dimensional gel 
electrophoresis (Zannis & Breslow，1981). Two different kinds of polymorphisms 
are associated with the apoE protein. 
1.4.1 Genetic Polymorphism 
As a result of two single nucleotide polymorphisms in exon 4 of the APOE 
gene, three different alleles (s2, e3 and E4) are found at the single APOE gene 
locus (Figure 1.1). Allelic frequencies vary in different populations (Table 1.2) 
with a general indication that the 83 allele is the most frequent while 82 is the 
rarest. The three apoE isoforms are designated as apoE2, apoE3 and apoE4, 
which show cysteine-arginine variation at amino acid residues 112 and 158 in 
the mature apoE protein. ApoESfthe most common isoform, has cysteine and 
arginine at position 112 and 158 respectively. ApoE2 has cysteine at both 
residues while apoE4 has arginine at both residues. Owing to the basic property 
of the amino acid arginine, apoE4 carries relatively the highest positive charge 
while apoE2 is associated with the lowest. The charge differences among the 
> 
apoE isoproteins accounted for the differences in isoelectric point can be 
detected by isoelectric focusing (Utermann et ai, 1977; Figure 1.2). 
« 
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Figure 1.2: Isoelectric focusing of delipidated apoE from three homozygous 
apoE phenotypes: E2/2, E3/3, and E4/4. The apoE2, apoE3 and apoE4 
isoforms differ sequentially by one charge unit as a result of the amino acid 
substitutions. The minor isoforms beneath each major apoE isoforms are the 
sialylated isoforms. (Mahley & Rail，2000) 
Table 1.2: Frequencies of the most common alleles for the gene locus 
coding for apoE and the corresponding apoE phenotypes in 11 
populations. 
Allelic 
Phenotype frequencies (%) 
Population frequencies (%) 
s2 83 E4 E2/2 E2/3 E3/3 E2/4 E3/4 E4/4 
Africans (Nigerians) 2.8 66.2 31.0 0.0 3.0 46.0 3.0 37.0 11.0 
African Americans 13.1 66.8 20.1 2.0 18.0 43.0 6.0 28.0 3.0 
American Indians 1.7 85.0 13.3 1.0 3.0 71.6 0.5 23.9 1.2 
Caucasinas 
Framingham, 
8.3 78.5 13.1 0.9 12.9 62.9 1.9 18.3 3.0 
Massachusetts 
Munster, 
8.2 78.2 13.6 0.9 11.7 62.2 2.9 19.9 2.2 
West Germany 
Finland 3.9 76.7 19.4 0.3 5.4 58.7 1.8 30.6 3.2 
France 8.1 80.2 11.7 0 . 8 � 1 3 . 1 64.3 1.6 18.7 1.6 
Italy 7.3 82.7 10.0 0.4 12.0 68.4 16.5 1.5 1.2 
Chinese 7.4 84.4 8.2 1.4 12.1 70.9 0.0 14.9 0.7 
- Japanese 3.7 84.6 11.7 0.3 6.1 71.9 0.7 19.3 1.7 
Mexican Americans 3.9 85.9 10.2 0.2 6.7 73.8 0.7 17.3 1.1 
(Eichner et ai, 2002) 
The expressions of any two of the three alleles result in three homozygous 
. -
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(apoE2/2, apoE3/3, and apoE4/4) and three heterozygous (apoE2/3, apoE3/4, 
and apoE2/4) phenotypes. In addition, the plasma apoE as well as lipid levels 
also depend on apoE genotypes. Compared to apoE3, apoE2 tends to be 
associated with increased levels of apoE but decreased levels of cholesterol. In 
contrast, apoE4 is associated with decreased apoE but increased cholesterol 
levels (Kao et aL, 1995; Sing & Davignon，1985; Utermann, 1985). Figure 1.3 
summaries the effects of apoE alleles on plasma apoE and lipid levels. 
A. B. 
5 r Q 10 r 
\ I • 
g • \ . • 
q - ISL a~gC) f 4 ^ 
e 3 \ o E 0 - • • J . . 83 
I • • 
1 iS 
~ I 1 1 1 1_L I I I ‘ ‘ 
2/2 3/2 3/3 4/3 4/4 ^ ^ ^ ^^  ^ 
Q Q Q 
J K J > 
ApoE Phenotype Lipids 
Figure 1.3: Effects of allelic difference at APOE gene locus on A) serum 
apoE concentration and B) lipid levels. A) Carriers of the 82 allele are 
associated with increased plasma apoE protein concentration while s4 carriers 
show the lowest plasma apoE level. B) TG: triglycerides; C: cholesterol; TC: 
‘ total cholesterol. Serum lipid levels, especially cholesterol, are affected by 
apoE genotypes. The s2 allele is associated with decreased cholesterol level 
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An isoform-specific binding capacity to the LDL receptors is also noted. Since 
the substitution of arginine by cysteine at position 158 in apoE2 is within the 
receptor binding domain of the apoE protein, apoE2 is defective in receptor 
binding while both apoE3 and apoE4 show normal binding (Mahley, 1988). On 
the other hand, the lipid binding capacity of apoE also shows isoform 
specificity. ApoE2 and apoE3 preferentially bind to the smaller, more 
phospholipids-enriched HDL while apoE4 preferentially binds to the larger, 
triglycerides-rich VLDL (Mahley & Rail，2000). 
1.4.2 Posttranslational Glycosylation 
Added to genetic variability, the attachment of variably sialylated carbohydrate 
moieties to the mature apoE protein also contributes to its polymorphic nature. 
0-linked glycosylation at a single site, threonine 194，imparts additional 
negative charges on the apoE proteins (Zannis & Breslow, 1981). The sialylated 
isoforms account for 10 % to 20 % of plasma apoE. The superimposition of 




1.5 Tissue Distribution of Apolipoprotein E 
The apoE protein is synthesized and secreted from a variety of organs. 
« 
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Significant quantities of apoE mRNA are detected in the liver, brain, spleen, lung, 
adrenal, ovary, kidney and muscle of several different species (Mahley, 1988). 
Figure 1.4 shows the relative amount of apoE mRNA detected in a wide range of 
organs from human. Liver, the major site of apoE synthesis, probably accounts 
for two-thirds to three-fourths of the plasma apoE (Mahley, 1988). The second 
largest site of synthesis is the central nervous system (CNS), in which the apoE 
proteins are distributed throughout all regions (Elshourbagy et al, 1985). Hepatic 
parenchymal cells and astrocytes are the cells responsible for producing apoE in 
liver and brain respectively (Mahley, 1988). Macrophages, active players in 
immune response, and smooth muscle cells (SMC), a component of blood vessels, 
also secrete large quantities of apoE (Mahley, 1988). The widespread distribution 
of apoE protein in both hepatic and extrahepatic sites indicates the indispensable 
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Figure 1.4: The relative amount of apoE mRNA in different human organs. 
• :Immune system H:Central nervous system QiMuscle HI :Secretory 
glands D :Others (http://genecarcls.bcgsc.ca/cgi-bin/carddisp?APOE) 
1.6 Functions of Apolipoprotein E 
1.6.1 Role of Apolipoprotein E in Lipid Metabolism 
Being an apolipoprotein, apoE maintains the structural integrity of lipoproteins 
and serves as a transporter of lipids from one tissue or cell type to another. 
ApoE accomplishes its lipid transport function through two receptor-mediated 
pathways: the highly regulatable low density lipoprotein (LDL) receptor and 
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1.6.1.1 Chylomicron Metabolism and Apolipoprotein E 
Chylomicrons synthesized by the intestine in response to dietary triglycerides 
and cholesterol acquire apoE from the circulation. Upon the hydrolysis of 
triglycerides by lipoprotein lipase in the plasma, the chylomicrons become 
cholesterol enriched and are referred to as chylomicron remnants. The 
clearance of chylomicron remnants from the plasma by liver is mediated by 
apoE via the HSPG/LRP pathway (Mahley, 1988; Mahley & Rail，2000). 
1.6.1.2 VLDL Metabolism and Apolipoprotein E 
VLDL carrying endogenously synthesized triglycerides, cholesterol and apoE 
are synthesized and secreted from the liver. Like chylomicrons, they become 
cholesterol enriched after the hydrolysis of triglycerides and are referred to as 
VLDL remnants. VLDL remnants are gradually converted to LDL by forming 
an intermediate, intermediate density lipoproteins (IDL). During the 
conversion cascade, apoE is lost as the particles become more cholesterol rich. 
In contrast to chylomicron remnants, the cellular uptake of VLDL remnants 
and IDL by peripheral tissues is mediated via the LDL receptors (Mahley, 
. 1988; Mahley & Rail，2000). 
) 
1.6.1.3 HDL Metabolism and Apolipoprotein E 
HDL is responsible for the transport of cholesterol from peripheral tissues to 
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liver, an important process termed reverse cholesterol transport. Excessive 
cholesterol in the circulation is accepted by non-apoE containing HDL. Once 
the HDL become cholesterol enriched, they acquire apoE from the circulation 
and accomplish reverse cholesterol transport by binding to hepatic LDL 
receptor via apoE. It should be noted that HDL lacking apoE do not bind to 
the LDL receptor. However, this direct ligand role of apoE in HDL 
cholesterol metabolism is less important in human as HDL with apoE is 
present in lower concentrations when compared to animals of lower classes 
(Mahley, 1988). Thus, reverse cholesterol transport in human seems to 
involve an additional pathway. Cholesterol on HDL is esterified by the 
enzyme, lecithin xholesterol acyl-transferase (LCAT) to cholesteryl esters 
which are then transferred to VLDL, IDL and LDL for receptor mediated 
uptake by liver. ApoE plays a fole in such pathway by promoting the transfer 
of cholesteryl esters from HDL to lower density lipoproteins (Mahley & Rail, 
2000). 
. 1.6.2 Lipid-independent Role of Apolipoprotein E 
I 
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1.6.2.1 Stimulation on Neurite Extension 
Being the apolipoprotein present at the highest concentration in the CNS, 
apoE plays an important role in nerve regeneration (Beffert et al., 1998; 
Mahley, 1988). Apart from participating in the redistribution of cholesterol 
from macrophages to the Schwann cells for remyelinization of the 
regenerated axons after injury, apoE can also be a neurotropic factor involved 
in events required for nerve survival and repair (Mahley, 1988; Swertfeger & 
Hui, 2001a). In fact, in vitro studies showed that the addition of apoE to 
dorsal root ganglion neurons would result in significant increase in neurite 
extension (Beffert et al” 1998; Swertfeger & Hui，2001a). 
1.6.2.2 Inhibition of Agonist-induced Platelet Aggregation 
Lipoproteins are capable of modulating the aggregatory ability of platelets; in 
which both apoE-containing subclass of HDL and apoE-rich VLDL are found 
to be the most potent in inhibiting platelet aggregation (Swertfeger & Hui, 
2001a). And the anti-aggregatory effect of apoE was found to be independent 
of its cholesterol-transport function (Swertfeger & Hui, 2001a). 
1.6.2.3 Immunoregulation 
Lipoproteins are found to be associated with immunoregulatory activity, 
which in fact, is attributed to their apoE content (Kelly et al” 1994; Mahley & 
« 
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Rail, 2000; Swertfeger & Hui，2001a). Both free apoE and those complexed 
with lipid are capable of suppressing lymphocyte proliferation by interfering 
with the primary inductive events associated with mitogenic activation of 
lymphocytes (Kelly et al, 1994; Swertfeger & Hui，2001a). The inhibition of 
apoE is believed not to involve the LDL receptor as the rarest isoform, apoE2, 
which is defective in LDL receptor binding, also retains the inhibitory activity 
(Mahley & Rail, 2000). 
1.6.2.4 Regulation of Androgen Synthesis by Ovary 
ApoE present in the follicles during ovarian follicularigenesis plays a vital 
role in regulating androgen synthesis (Swertfeger & Hui, 2001a). It is 
interesting to note that apoE regulation of androgen synthesis is concentration 
dependent, with androgen synthesis stimulated at low concentrations but 
inhibited at high concentrations of apoE (Swertfeger & Hui, 2001a). The 
modulatory effect of apoE on androgen production is believed to proceed via 
a mechanism independent of cholesterol transport and utilization as the 
V 
regulation could still be demonstrated in vitro using serum-free medium and 
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1.7 Association Between Various Disorders and Apolipoprotein E 
Despite of its diverse functions in cellular responses, apoE is also associated with 
several disorders and shows an isoform-dependent pattern, including type III 
hyperlipoproteinemia, Alzheimer's disease and atherosclerosis. 
1.7.1 T^pe III Hyperlipoproteinemia and Apolipoprotein E 
Owing to its defective binding to LDL receptors on cell surfaces for the 
clearance of remnant lipoproteins in circulation, the s2 allele is associated with 
the highest frequency of developing type III hyperlipoproteinemia among the 
three isoforms (Mahley, 1988). It is a lipoprotein disorder characterized by 
elevated plasma levels of cholesterol and triglycerides (Mahley & Rail, 2000). 
1.7.2 Alzheimer's Disease and Apolipoprotein E 
Alzheimer's disease (AD) is a neurodegenerative disorder of the brain 
characterized by the presence of neuritic amyloid-containing senile plaques 
(SPs) and intraneuronal neurofibrillary tangles (NFTs) (Beffert et aL, 1998; 
Strittmatter, 1996). The 84 allele represents the most important genetic risk 
V 
factor for AD (Beffert et aL, 1998; Neve & Robakis’ 1998). About 80 % of 
. familial and 64 % of sporadic late-onset AD cases carry at least one copy of the 
> 
s4 allele compared to 31 % of controls (Beffert et aL, 1998). Nevertheless, it 
should be noticed that not everyone possessing the 84 allele will develop AD 
« 
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and many AD patients lack the allele. 
The age of onset, density of SPs, amount of NFTs and volume of hippocampus 
are correlated to apoE genotype in a gene dosage-dependent manner (Beffert et 
al.，1998; Laws et ai, 2003). Each additional 84 allele shifts the age of onset to 
a younger age, increases the SPs density and NFTs counts as well as decreases 
hippocampus volumes (Beffert et ai, 1998; Laws et ai, 2003). In contrast to 
the increased 84 allele frequency in AD, several studies demonstrated a 
decrease in the frequency of s2 allele in AD patients, and this suggests a 
possible protective property of the 82 allele (Beffert et al, 1998; Mahley & 
Rail , 2000). These findings are further supported by the odd ratios of 
developing AD among Caucasian populations in which the values of 82/83, 
E2/S4, 83/84, 84/84 genotypes are 0.6，2.6, 3.2 and 14.9, respectively, relative to 
83/83 genotype (Beffert et al” 1998). 
1.7.3 Atherosclerosis and Apolipoprotein E 
Atherosclerosis is a slow, complex disease mainly affecting large- and 
medium-sized arteries, and is characterized by the deposits of fatty substances, 
, cholesterol, calcium and other cellular waste products in the inner lining of the 
arteries. This buildup constitutes the formation of plaque at the site of lesion 
and causes local occlusion of the arteries (Davignon et ai, 1999; Harris et al” 
« *  
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2002). ApoE is found to be protective against the development of this disease. 
In fact, apoE-knock out mouse has been used extensively as animal model for 
the study of atherosclerosis as it develops severe hypercholesterolaemia and 
atherosclerotic lesions similar to those found in human (Harris et al, 2002). 
The protection of apoE against atherosclerosis is multifactorial, including the 
promotion of lipoprotein clearance from the circulation (Mahley, 1988) and 
cholesterol efflux from peripheral cells (Yoshida et al, 2001). Other 
anti-atherogenic properties of apoE unrelated to lipid metabolism are attributed 
to its ability to inhibit lipoprotein oxidation (Faggiotto et al” 1998) and platelet 
aggregation (Riddell et al” 1997), prevent monocyte recruitment (Nakashima et 
al” 1998)，inhibit lymphocyte activation and proliferation (Vogel et ai, 1994) 
and SMC migration and proliferation (Ishigami et al” 1998). 
ApoE2 carriers who develop type III hyperlipoproteinemia are more vulnerable 
to atherosclerosis, owing to the increased plasma lipid levels (Harris et al, 
2002). However, a conclusive correlation between apoE polymorphism and risk 
V-
of atherosclerosis has not yet been established (Eichner et al” 2002). It is 
, generally believed that apoE3 is the most protective among the 3 common 
I 
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1.8 Cell Proliferation and Cell Cycle Progression 
In order to maintain normal tissue homeostasis, the balance between cell 
proliferation and cell death must be tightly regulated, and this ultimately 
determines cell fates in the cell cycle. 
Actively dividing cells undergo two consecutive processes, DNA replication and 
segregation of replicated chromosomes, which are separated by two gap phases 
and these four stages are the traditional subdivisions of the standard cell cycle 
(Figure 1.5). At Gi phase, cells are preparing for DNA synthesis in S phase, 
followed by G2 phase, during which cells are preparing for mitosis in M phase. 
Cells in Gi phase can also enter a resting state, Go phase. Cells in Go phase 
account for the major part of the non-growing, non-proliferating quiescent cells 
in the human body. The transition from one cell cycle phase to another is highly 
regulated by cellular proteins called cyclin-dependent kinases (CDKs). 
« " 
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Figure 1.5: Overview of the mammalian cell cycle. The mammalian cell cycle 
basically consists of four phases: first gap phase (Gi), DNA synthesis (S), second 
gap phase (G2) and mitosis (M). The transition between different phases is 
regulated by cyclin/CDK complexes. Different cyclins (A, B, D, E) are present 
during different phases and interact with different CDKs. As long as growth 
factors are present, cells will continue to proliferate. In the absence of growth 
factors, cells beyond the restriction point (R) will complete the cycle and enter 
the quiescent state (Go), (modified from Hulleman & Boonstra，2000) 
1.8.1 Cyclin-dependent Kinases and Cyclins 
CDKs belong to a family of serine/threonine protein kinases that are activated 
at specific points of the cell cycle. There are nine CDKs being identified at the 
present of which only five of them participate in the progression of cell cycle 
V. 
(Vermeulen et ai, 2003a). Activation of CDKs depends on their interaction 
‘ with the activating proteins, cyclins. The protein levels of cyclins rise and fall 
during the cell cycle so that they periodically activate CDKs (Figure 1.6) 
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(Hulleman & Boonstra，2000). 
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Figure 1.6: Expression of cyclins during the mammalian cell cycle. Upon 
stimulation of quiescent cells (Go), different cyclins are expressed in an orderly 
way. Cyclin D is absent in quiescent cells but rapidly accumulates after growth 
factor stimulation. Cyclin D is subsequently expressed constitutively 
throughout subsequent cell cycles, whereas expression of cyclins E, A and B is 
related to a specific cell cycle phase. (Hulleman & Boonstra, 2000) 
For both CDKs and cyclins, different members are required at different phases 
of the cell cycle (Figure 1.5 & 1.6; Table 1.3). However, CDK7-cyclin H 
complex is required in all phases for its phosphorylation of threonine residues 
of CDKs, which induces conformational changes and thus enhances the binding 
of cyclins (Vermeulen et al, 2003b). When activated, CDKs phosphorylate 
V-
downstream target proteins on CDK consensus sites, resulting in responses that 
‘ are physiologically relevant for cell cycle progression (Morgan, 1995). 
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Table 1.3: Cyclin-CDK complexes at specific points of the cell cycle. 
CDK Cyclin Cell Cycie Phase  
CDK4 Cyclin Dl , D2，D3 Gi phase 
CDK6 Cyclin Dl , D2, D3 Gi phase 
CDK2 Cyclin E Gi/S phase transition 
CDK2 Cyclin A S phase 
CDKl Cyclin A G2/M phase transition 
CDKl Cyclin B M phase 
CDK7 Cyclin H M  
1.8.2 Cyclin-dependent Kinases and Their Inhibitors 
The activity of CDKs can be counteracted by cell cycle inhibitory proteins, 
CDK inhibitors (CKIs) (Vermeulen et al” 2003b). Two distinct families of 
CKIs have been discovered, the INK4 family and Cip/Kip family (Table 1.4) 
(Sherr & Roberts，1995). Members of the INK4 family form stable complexes 
with CDKs before cyclins binding, preventing their association with cyclins 
while CKIs from the Cip/Kip family inhibit the kinase activities of cyclin/CDK 
complexes (Vermeulen et al” 2003a). 
Table 1.4; Two families of CKIs and their respective functions. 
CKI family Function Family members 
INK4 family Inactivation of Gi CDK p l 5 
p l 6 
p l 8 
p l 9  
‘ Cip/Kip family Inactivation of Gi cyclin-CDK p21 
• complexes, cyclin E-CDK2 & p27  
cyclinB-CDKl p57  
« 
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1.8.3 Restriction Point in Cell Cycle 
Restriction point (R) is defined as a point in Gi phase (Figure 1.5), after which 
the cell is committed to a complete cell cycle even in the absence of growth 
factors. Cells starved of serum before R enter Go state while cells starved after 
R are unaffected and continue through mitosis. Expression of E-type cyclins 
and the subsequent activation of CDK2, which is responsible for Gi/S phase 
transition, act as the R switch. 
1.9 Cell Proliferation and Mitogen-activated Protein Kinase (MAPK) 
Cell cycle progression is regulated by both intracellular, such as DNA damage, 
and extracellular, such as presence of growth factors, control mechanisms. The 
transmission of stimuli to nuclei for the corresponding cellular responses depends 
on intracellular signal transduction cascades. Mitogen-activated protein kinase 
(MAPK) signaling system, an evolutionarily conserved module of three 
sequentially activated protein kinases, is one of the most important signaling 
pathways inside mammalian cells. MAPKs regulate many cellular processes, 
from gene expression to cell death, particularly the progression of cell cycle. 
» 
1.9.1 Organization of MAPK Signaling Pathway 
The core of this cascade consists of three protein kinases: MAPK activation 
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requires phosphorylation on conserved threonine and tyrosine residues by a 
MAPK kinase (MAPKK), which itself is activated by phosphorylation on 
conserved serine and threonine residues by a MAPKK kinase (MAPKKK) 
(Wilkinson & Millar, 2000). The activated MAPKs exert their effects by either 
phosphorylating cytoplasmic targets or translocating into nuclei to modulate the 
activity of transcription factors. All MAPKs recognize similar phosphoacceptor 
sites composed of serine or threonine followed by a proline, with the 
surrounding amino acids contributing to substrate specificity. 
In mammals, there are at least four distinctly regulated groups of MAPKs: 
extracellular signal-related kinases (ERKl/2), Jun amino-terminal kinases 
(JNKl/2/3)，p38 proteins (pSSa/p/y/S), and ERK5. Each MAPK is activated by 
a specific MAPKK, which, however, can be activated by more than one 
MAPKKK; this increases the complexity and diversity of MAPK signaling 
cascade (Figure 1.7) (Hazzalin & Mahadevan，2002). Each module is 
responsible for different cellular responses, including cell proliferation and 
、 
‘ differentiation, inflammation and apoptosis. ERKl/2 is the most extensively 
studied MAPK while ERK5 is the least understood. All the ERK MAPKs \ 
possess the. conserved phosphorylation motif, threonine-X-tyrosine (TXY). 
However, the presence of a large, unique carboxyl terminal domain 
i 
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distinguishes ERK5 from ERKl/2 (Kato et ai, 2000; Kasler et ai, 2000). Both 
MAPK modules are thought to participate in the regulation of cell proliferation 
either by phosphorylating downstream targets or modulating gene expression. 
Inflammatory cytokines, Stress, 
Cri^ owtli factor 
Stimulus Cellular stress, UV-irradiation Serum 
, 一 , , TPL NfEKK \ � 
MAPKKK ^ K T A K A S I ^ CMEKES) 
T J � i L 
MAPKK CjgEKVi) C ^ ^ J ) Cj^EJ^) 
M ^ K 声 C i > i C&； 
Substrate: ( J ^ ^ ^ t ) / \ J • \ 
Response: Proliferation, Differentiation, Inflammation, Proliferation 
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Figure 1.7: Schematic representation of mammalian MAPK cascades and target 
substrates. The four characterized MAPKs comprise the extracellular-signal 
regulated kinase (ERKl/2), Jun amino-terminal kinase (JNK), p38 and big MAPK 
(ERK5). Upon stimulation, sequential phosphorylation is initiated and the activated 
MAPKs phosphorylate their downstream targets, resulting in the corresponding 
cellular responses, (modified from Hazzalin & Mahadevan，2002) 
1.9.2 Regulation of Cell Proliferation via Activator Protein-1 (AP-1) 
* 
\ 
Being a transcriptional activator, AP-1 regulates a wide range of cellular 
processes, including cell proliferation (Shaulian & Karin, 2002). AP-1 is not a 
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single protein, but a dimeric protein with its subunit composed of members 
from the Jun and Fos families (Karin, 1995; Shaulian & Karin，2002). The 
regulation of AP-1 activity occurs at transcriptional, translational and 
post-translational levels (Shaulian & Karin，2002). Upon serum and growth 
factor stimulation, the MAPKs, ERKl/2 as well as ERK5, are activated and 
induce fos and jun gene transcription. The translational products are also 
phosphorylated by the MAPKs, which enhances their dimerization to form 
AP-1. AP-1 stimulates cell cycle progression by inducing cyclin D1 
transcription (Chang & Karin, 2001; Terada et ai, 1999) and repressing p21 
transcription (Shaulian & Karin, 2002; Xiong et ai, 1993). 
1.9.3 Regulation of Cell Proliferation via c-Myc 
Apart from AP-1, MAPKs also modulate cell proliferation via the transcription 
factor, c-Myc, which plays an important role in regulating the transition from 
Go to S phase of the cell cycle (Vermeulen et ai, 2003a). The expression level 
of c-Myc is regulated by the Ras/Raf/MEK/ERK pathway at transcriptional, 
V 
“ translational and post-translational levels (Vermeulen et ai, 2003a). In addition, 
the newly explored MAPK, ERK5, also regulates c-Myc post-translationally 
» 
(English et ai, 1998). C-Myc exerts its effect on cell cycle progression by the 
transcriptions of genes, such as cyclin D1 and D2, cyclin E, cyclin A, cdkl , 
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cdk2, cdk4, and E2F (Vermeulen et al” 2003b). 
1.10 Cell Proliferation and Apolipoprotein E 
The anti-proliferative property of apoE was first identified by Okano et al. in 
1985. It was found that purified delipidated apoE was capable of suppressing 
peripheral blood mononuclear and T cell proliferation when stimulated in vitro 
with polyclonal mitogens (Okano et ai, 1985). In fact, the apoE content was 
later nominated to be responsible for the immunoregulatory potency of plasma 
lipoproteins (Kelly et ai, 1994). 
1.10.1 Effects of Exogenous Apolipoprotein E on Cell Proliferation 
In the past decade, the inhibitory effect of apoE on proliferation was studied 
in a variety of cell types using recombinant human apoE protein 
supplemented exogenously (Vbgel et al” 1994; Ishigami et al” 1998; 2000; 
Paka et al” 1999 & Swertfeger & Hui，2001b). Vascular SMC gained 
attention since one of the anti-atherogenic effects of apoE was attributed to its 
、 
ability to inhibit SMC proliferation (Ishigami et al” 1998; 2000; Paka et al” 
1999 & Swertfeger & Hui，2001b). Among the three isoforms, only the 
» 
anti-proliferative property of apoE3 was well documented while little was 
�‘ 
known for the other two isoforms. Until recently, it was reported that the 
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three isoforms showed preferences of inhibiting SMC migration and 
proliferation, with apoE3 giving the most prominent effects (Zeleny et al” 
2002). Though the anti-proliferative effects of apoE3 have been extensively 
studied, the mechanisms behind such effects are not well understood. 
1.10.2 Effects of Endogenous Apolipoprotein E on Cell Proliferation 
Previously, a fibroblast cell line without native apoE expression was 
employed as the study model to investigate the effects of endogenously 
expressed apoE3 on cell proliferation (Ho et ai, 2001). Consistent with the 
exogenous protein, endogenously expressed apoE3 exerted an inhibitory 
effect on fibroblast growth by preventing the activation of ERKl/2 MAPK 
(Ho et al” 2001). Nevertheless, the effects of endogenous expression of the 
other 2 isoforms, apoE2 and apoE4 on cell proliferation have not been studied 
before. -
1.11 Aims and Scopes of Study 
In the present study, the anti-proliferative effects of endogenously expressed 
apoE isoforms are investigated in a rat embryonic fibroblast cell line. It is 
t 
hypothesized that endogenously expressed apoE proteins exert isoform-specific 
effects on cell proliferation via similar molecular mechanisms. To test this 
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hypothesis, stable cell lines are generated by transfection with vector control 
and apoE isoform-encoding plasmids, with the apoE2 and apoE4 constructs 
prepared from the apoE3 cDNA by site-directed mutagenesis. The expression 
levels of apoE proteins are analyzed by both western blot and enzyme-linked 
immunosorbent assays. Cell lines with similar apoE protein levels are then 
chosen for further characterization of the isoform-specific effects of apoE on 
cell proliferation. 
The effects of apoE isoforms on growth rate, DNA synthesis and cell cycle 
progression are studied by direct cell count, ^H-thymidine incorporation and 
flow cytometry analyses respectively. Furthermore, the involvement of different 
MAPK, including ERKl/2 and ERK5, and transcription factors, c-Jun and 
c-Myc，in the anti.-proliferative effects of apoE isoforms on fibroblasts are 
elucidated using western blot. -Lastly, the expression profiles of cell cycle 
control genes in response to the expression of apoE isoforms are studied by the 
real time polymerase chain reaction (PCR) technique. 
The findings in this thesis shed lights to better understanding of the mechanisms 
underlying the anti-proliferative property of apoE isoforms and thus the 
* 
\ 
development of various diseases, such as atherosclerosis and AD. 
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2 Materials & Methods 
2,1 Materials 
2.1.1 Construction of ApoE Isoform-encoding Piasmids 
2.1.1.1 Human ApoE3 cDNA 
The human apoE3 cDNA was purchased from Mammalian Gene Collection 
(Invitrogen, Life Technologies, Carlsbad, CA, USA). 
2.1.1.2 Mammalian Expression Vector 
The mammalian expression vector, pcDNA3.l/Hygro(+), was purchased from 
Invitrogen, Life Technologies (Carlsbad, CA, USA). 
2.1.1.3 Reagents for Agarose Gel Electrophoresis 
1) Agarose Gel 
DNA fragments were separated on 1 % (w/v) agarose gel (Sigma, St. Louis, 
MO, USA). 
2) Electrophoresis Apparatus 
Wide mini-sub cell GT systems were purchased from Bio-Rad Laboratories 
(Hercules, CA, USA). 
3) Tris-borate-EDTA (TBE) Electrophoresis Buffer (5X) 
� Stock TBE buffer (5X) was prepared by dissolving 54 g of Tris base (0.45 M) 
(Amersham Biosciences, Buckinghamshire，UK), 27.5 g of boric acid (0.45 
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M) and 20 ml of 0.5 M EDTA (Sigma, St Louis, MO, USA) in double 
distilled water to a total volume of 1 liter with pH calibrated to 8.0 using 6 N 
HCl or 2 M NaOH. Working solution (IX) was prepared by diluting the stock 
buffer by 5 fold. Both stock and working solutions were kept at room 
temperature. 
4) Gel Loading Solution (6X) 
Loading dye was prepared by mixing 0.25 % (w/v) bromophenol blue 
(Amersham Biosciences, Buckinghamshire, UK), 0.25 % (w/v) xylene cyanol 
FF (ICN BioMedicals Inc, Irvine, CA, USA), and . 40 % (v/v) glycerol 
(Amersham Biosciences, Buckinghamshire, UK) in autoclaved double 
distilled water. Stock was kept as aliquots of 1 ml at -20 °C while the 
working dye was stored at 4 °C. 
5) Ethidium Bromide (EtBr) 
EtBr was prepared as 10 mg/ml stock solution (Amresco, Ohio, USA) and 
kept in dark at room temperature. 
6) DNA Ladder Marker 
The 100 bp and 1 kbp DNA markers were purchased from Fermentus 
, (Hanover, MD, USA). The working solution was prepared by mixing 1 
volume of stock DNA markers and 1 volume of 6X loading dye with 4 
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volumes of autoclaved double distilled water. The stock solution was kept 
at - 20 °C while the working solution was stored at 4 °C. For each agarose gel, 
1.5 |Lil of working solution was loaded. 
7) Gel Extraction Kit 
DNA fragments from agarose gel were purified by MinElute Gel Extraction 
Kit purchased from Qiagen (Valencia, CA, USA). 
2.1.1.4 Reagents for Ligation Reaction 
1) Restriction Enzymes 
Kpnl and Xbal were purchased from Fermentus (Hanover, MD，USA) and 
Amersham Biosciences (Buckinghamshire, UK), respectively. 
2) One-Phor-All Plus (OPA+) Buffer 
Enzymatic digestion with both enzymes was performed simultaneously in 
OPA+ buffer from Amersham Biosciences (Buckinghamshire, UK). 
3) T4 DNAIigase 
Ligation reaction was carried out using T4 DNA ligase purchased from 
Fermentus (Hanover, MD, USA). 
2.1.1.5 Bacterial Culture Medium 
* , • . 
1) Luria broth (LB) Medium and LB Agar 
They were purchased from USB (Swampscott, MA, USA). 
‘ 31 
Chapter 2: Materials & Methods 
2) Ampicillin 
A stock solution (5 mg/ml) of ampicillin (Amersham Biosciences, 
Buckinghamshire, UK) was prepared in autoclaved double distilled water. 
The working solution (50 fig/ml) was prepared by diluting the stock solution 
100 fold in LB medium or LB agar before use. The stock solution was kept 
at - 20 °C. 
2.1.1.6 Reagents for Polymerase Chain Reaction (PCR) 
1) DNA Taq Polymerase and Deoxyribonucleoside Triphosphate (dNTP) 
Mix 
Taq polymerase (Thermus aquaticus) supplied at 5 U/|il together with lOX 
reaction buffer and 20 mM dNTP mix were purchased from Amersham 
Biosciences (Buckinghamshire, UK). The lOX reaction buffer contained 100 
mM Tris-HCl, pH 9.0, 15 mM MgCh solution, and 500 mM KCl. They were 
stored at -20 °C. 
2) Primer Pairs 
The oligonucleotide primers were designed on the basis of the published 
sequences of the human APOE gene (Table 2.1) and synthesized by 
* 
� Invitrogen, Life Technologies (Carlsbad, CA, USA). The lyophilized primer 
pairs were reconstituted in autoclaved double distilled water to a stock 
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concentration of 100 |aM. A working solution of 10 jiM was diluted from the 
stock solution by adding 10 jil of stock solution to 90 of autoclaved double 
distilled water. Both the stock and working solution were kept at -20 °C. 
Table 2.1: Primer sequences for PCR checking of apoE cDNA.  
Sequence Product Size 
Forward 5 ‘ ACGCGGGCACGGCTGTCCAA 3 ‘ 
4 3 0 
Reverse 5 ‘ TCCTTCACCTCGTCCAGGCG 3 ‘ 
3) Dimethyl Sulfoxide (DMSO) 
DMSO was purchased from Sigma (St. Louis, MO, USA). 
2.1.1.7 Site-directed Mutagenesis 
1) QuikChange Site-directed Mutagenesis Kit 
It was purchased from Stratagene (La Jolla, CA, USA). 
2) Primer Pairs 
The oligonucleotide primers were designed on the basis of the published 
sequence of the human APOE gene with a single point of mutation at the 
middle and synthesized by Invitrogen, Life Technologies (Carlsbad, CA, 
USA). The primer pairs were handled in the same way as mentioned in 
section 2.1.1.6. 
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Table 2.2: Primer sequences for ApoE2 and ApoE4 constructs. 
Name Sequence 
A p o E 2 Forward 5‘GATGACCTGCAGAAGTGCCTGGCAGTGTACCAGG 3 ' 
Reverse 5‘ CCTGGTACACTGCCAGGCACTTCTGCAGGTCATC 3 ' 
A p o E 4 Forward 5^ GACATGGAGGACGTGCGCGGCCGCCTGGTGC 3 ' 
Reverse 5‘GCACCAGGCGGCCGCGCACGTCCTCCATGTC 3 ' 
3) Plasmid Purification Kit 
Plasmids from overnight bacterial culture were purified by the UNIQ-10 Spin 
Column Plasmid DNA Minipreps Kit from BioBasic Inc. (Ontario, Canada). 
2.1.2. Establishment of ApoE Isoform-expressing Cell Lines 
2.1.2.1 F i l l Rat Embryonic Fibroblasts 
The cell line was a generous gift from Dr. David. A Talmage (Columbia 
University, NY, USA). 
2.1.2.2 Reagents for Cell Culture 
1) High Glucose Dulbecco's Modified Eagle's Medium (DMEM) 
The powder form of high glucose DMEM medium (Gibco BRL Life 
Technologies, Inc, Carlsbad, CA, USA), with 4,500 mg/L D-glucose, 4 mM 
� L-glutamine, 110 mg/L sodium pyruvate and 4 mg/L pyridoxine HCl, was 
used for sub-culturing of F i l l cells. The powder was dissolved in double 
« 
‘ distilled, water and buffered with 3.7 g of sodium bicarbonate (Sigma, St. 
Louis, MO, USA) per liter. The pH value of the medium was adjusted to 
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7.2-7.4 by 6 M HCl (Sigma, St. Louis, MO, USA) and the medium was then 
sterilized by filtration through 0.22 |im filter (Millipore, Billerica, Mass, USA) 
and stored at 4 until use. 
2) Serum Supplements 
Calf serum (CS) purchased from Gibco BRL Life Technologies, Inc. 
(Carlsbad, CA, USA) was stored as 50 ml aliquots in sterile centrifuge tubes 
a t -20°C. 
3) Antibiotic Mixture Solution 
Penicillin-Streptomycin (PS) antibiotic mixture in lOOX stock solution 
containing 10,000 units/ml penicillin G sodium plus 10,000 |ig/ml 
streptomycin sulfate in 0.85 % saline was purchased from Gibco BRL Life 
Technologies, Inc. (Carlsbad, CA, USA). It was stored as aliquots of 10 ml in 
sterile centrifuge tubes at -20 °C. The lOOX stock solution was added to 
DMEM medium to give 1 % (v/v) solution to prevent contamination of cell 
culture. 
4) Phosphate-Buffered Saline (PBS) 
Stock PBS solution (lOX) was prepared by dissolving 80 g of sodium 
‘ chloride (NaCl) (1370 mM), 2 g of potassium chloride (KCl) (27 mM), 14.4 g 
of dibasic sodium phosphate (Na2HP04) (100 mM), 2.4 g of monobasic 
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potassium phosphate (KH2PO4) (20 mM) (Sigma, St. Louis, MO, USA) in 1 
liter of double distilled water. A working solution (IX) was prepared by 
diluting 100 ml of lOX PBS (warm before use) with 900 ml of double 
distilled water and then sterilized by autoclaving at 121 °C for 20 minutes. It 
was stored at 4°C until use. 
5) Trypsin-EDTA Solution 
Trypsin-EDTA solution containing 0.05 % trypsin and 0.53 mM EDTA-4Na 
in Hanks' balanced salt solution was purchased from Gibco BRL Life 
Technologies, Inc. (Carlsbad, CA, USA). It was stored at -20 as aliquots 
of 50 ml. 
2.1.2.3 Cell Culture Wares 
Glasswares used for sub-culture and experiments, including 75 cm^ flasks, 60 
mm dishes, 100 mm dishes, multi-well plates and centrifuge tubes were all 
purchased from Iwaki (Chiba, Japan). 
2.1.2.4 Reagents for Transfection 
� LipofectamineTM 2000 Reagent and the selection marker, hygromycin B, were 
purchased from Invitrogen, Life Technologies (Carlsbad, CA, USA). 
» 
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2.1.2.5 Reagents for Protein Assay 
1) Detergent Compatible (DC) Assay Kit 
Protein concentration was measured by DC protein assay kit from Bio-Rad 
Laboratories (Hercules, CA, USA). 
2) Bovine Serum Albumin (BSA) 
BSA standards (Sigma, St. Louis, MO, USA) were prepared as 1 mg/ml stock 
in autoclaved double distilled water and aliquots of 500 ]x\ was stored at - 2 0 
3) Spectrophotometric Cuvette 
The 1 ml plastic cuvette used for spectrophotometry was purchased from 
Sarstedt (Numbrecht, Germany). 
2.1.2.6 Reagents and Buffers for Western Blot Analysis 
1) Cell Lysis Buffer 
The cell lysis buffer containing 1 % SDS, 1 mM sodium orthovanadate 
(Na3V04)，10 mM Tris (pH 7.4)，21 |ig/ml aprotinin, 5 i^g/ml leupeptin, 1 
� mM phenylmethylsulfonyl fluoride (PMSF) and 5 mM magnesium chloride 
(MgCh) was prepared in autoclaved double distilled water. Aliquots of 1 ml 
� were kept at 4 � C until use. 
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2) 30 % (w/v) Acrylamide / Bis Solution, 37.5:1 
The ready-to-use 500 ml acrylamide solution containing 30 % (w/v) of 
acrylamide (146.1 g) and N,N‘-methylene-bis-acrylamide (3.9 g) for a total 
monomer to crosslinker ratio of 37.5:1 was purchased from Bio-Rad 
Laboratories (Hercules, CA, USA). It was light-protected and stored at 4 � C 
until use. 
3) Stacking Gel Buffer 
It was a 0.5 M Tris-HCl buffer containing 0.4 % SDS adjusted to pH 6.8 and 
kept at 4 � C . 
4) Running Gel Buffer 
It was a 1.5 M Tris-HCl buffer containing 0.4 % SDS adjusted to pH 8.8 and 
kept at 4 � C . 
5) 10 % Ammonium Persulfate (APS) 
APS (10%, w/v) purchased from USB (Swampscott, MA, USA) was freshly 
prepared before use. 
6) N，N，N，，N，-Tetra-methylethylenediamine (TEMED) 
TEMED purchased from Bio-Rad Laboratories (Hercules, CA, USA) was the 
‘ last to add to initialize the polymerization of the SDS-polyacrylamide gel. It 
was stored at 4 °C until use. 
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7) SDS Gel Loading Buffer (4X) 
SDS gel loading buffer (4X) containing p-mercaptoethanol (Bio-Rad 
Laboratories, Hercules, CA, USA) and bromophenol blue was prepared by 
mixing 0.4 ml of 1% (w/v) bromophenol blue, 1 ml of 0.5 M Tris-HCl at pH 
6.8，1.6 ml of glycerol, 1.6 ml of 20 % (w/v) SDS, 4.2 ml of double distilled 
water and 0.3 ml of p-mercaptoethanol. Aliquots of 1 ml were prepared and 
stored at 4 °C until use. 
8) Prestained Protein Standard 
The prestained SDS-PAGE standards (broad range)' were purchased from 
Bio-Rad Laboratories (Hercules, CA, USA). It consisted of eight colored 
proteins with their molecular weight calibrated for each lot. The standard 
colored proteins prepared in 33 % (v/v) glycerol, 3 % SDS, 10 mM Tris (pH 
7)，10 mM DTT, 2 mM EDTA and 0.01 % N a N � were stored at - 2 0 °C until 
use. 
9) Tris-GIycine-SDS Electrophoresis Buffer (lOX) 
� The lOX electrode buffer containing 30 g of Tris base (0.25 M) at pH 8.3, 
144.1 g of glycine (1.92 M) and 50 ml of 20 % SDS (1 %) in 1 liter of double 
� distilled water was stored at room temperature. The lOX concentrate was 
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diluted to IX working buffer solution with double distilled water for 
SDS-PAGE. 
10) Coomassie Blue Staining and Destaining Solution 
The staining solution was prepared by dissolving 0.25 g of Coomassie R-250 
with 10 ml of acetic acid, 50 ml of methanol and 50 ml of double distilled 
water. The mixture was stirred for 2 hours and then stored at room 
temperature. For the destaining solution, it was prepared by mixing one 
volume of acetic acid, three volumes of methanol and ten volumes of double 
distilled water. 
11) Tris-Glycine Buffer (lOX) 
Tris-glycine lOX buffer containing 30 g of Tris base (0.25 M) and 140 g of 
glycine (1.9 M) in 1 liter of double distilled water was stored at room 
temperature. 
12) Tris-Glycine-methanoI Transfer Buffer (IX) 
The .transfer buffer was prepared by mixing 100 ml of methanol with 100 ml 
� of lOX concentrate of Tris-glycine buffer and 800 ml of double distilled 
water. The buffer solution was freshly prepared before use. 
> 
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13) Hybond ECL nitrocellulose membrane 
The nitrocellulose Hybond ECL membrane was purchased from Amersham 
Biosciences (Buckinghamshire, UK) and kept at room temperature. 
14) Electrophoresis and Transfer Apparatus 
Mini-Protein 3 electrophoresis cell systems were purchased from Bio-Rad 
Laboratories (Hercules, CA, USA). 
15)Tris-buffered Saline (TBS) 
TBS lOX concentrate containing 24.2 g of Tris base (0.2 M)，80 g of NaCl 
(1.37 M) and 38 ml of 1 M HCl was adjusted to pH 7.6 and stored at room 
temperature. 
16)TBS-Tween (Washing Buffer) 
The washing buffer was prepared by adding 1 ml of Tween-20 (USB, 
Swampscott, MA, USA) in 100 ml of lOX TBS and 900 ml of double 
distilled water. The solution was freshly prepared before use. 
17)5% Nonfat Milk Solution (Blocking Buffer) 
� It was prepared by dissolving nonfat milk powder (Carnation) in washing 
buffer at a concentration of 5 % (w/v). 
* • 
‘ 1 8 ) Primary Antibody 
Goat polyclonal anti-human apoE antibody (BioDesign, Saco, ME, USA) was 
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supplied at a concentration of 1 mg/ml. The antibody was stored as small 
aliquots at - 2 0 � C . 
19) Secondary Antibody 
Rabbit anti-goat IgG, peroxidase-linked species-specific whole antibody was 
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). It 
was supplied at a concentration of 0.4 mg/ml and stored at 4 °C. 
20) ECL™ Western Blotting Detection Reagents 
The Western blotting detection reagents (Amersham Biosciences, 
Buckinghamshire, UK) which contain detection reagent 1 and 2 were stored 
at 4 � C . 
21) X-ray film 
The X-ray film was purchased from Roche Applied Science (Indianapolis, IN, 
USA) and stored in dark at room temperature. 
22) Stripping Solution 
It was prepared by mixing 29.22 g of NaCl (0.5 M) with 30 ml of acetic acid 
(30 %, v/v) in 1 liter of double distilled water and stored at room temperature. 
2.1.2.7 Reagents for Enzyme-linked Immunosorbent Assay (ELISA) 
1) Ninety-six-well Immunolon Plates 
The immunolon plates were purchased from Nalge Nunc International 
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(Rochester, NY, USA). 
2) Recombinant Human ApoE3 Protein 
The recombinant human apoE proteins produced by baculovirus-mediated 
expression in the Spodoptera frugiperda insect cell line were obtained from 
Research Diagnostics, Inc. (Flanders, NJ, USA). 
3) Coating Antibody 
Goat polyclonal anti-human apoE antibody (BioDesign, Saco, ME, USA) was 
the same as the primary antibody used in western blot analysis. 
4) Secondary Antibody 
Goat biotin-conjugated anti-human apoE antibody (BioDesign, Saco, ME, 
USA) was supplied at a concentration of 0.8 mg/ml. The antibody was stored 
as small aliquots at - 2 0 °C. 
5) Conjugation Enzyme and Substrate 
The conjugate enzyme, avidin peroxidase and the substrate, 
2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) were 
purchased from ICN BioMedicals Inc. (Irvine, CA, USA). 
6) Hydrogen Peroxide, 30% (v/v) (H2O2) 
’ It was purchased from Sigma (St. Louis，MO, USA). 
7) Coating Buffer 
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The 0.1 M sodium bicarbonate coating buffer at pH 9.6 was prepared in 
advance and stored at 4 � C . 
8) Washing Buffer 1 
Washing buffer 1 was prepared by adding 0.5 % (v/v) Tween-20 in IX PBS. 
9) Washing Buffer 2 
Washing buffer 2 was prepared by adding 5 % (w/v) nonfat milk powder in 
washing buffer 1. The solution was freshly prepared before use. 
10) Blocking Buffer 
Blocking buffer was freshly prepared by adding 3 %' BSA (w/v) in washing 
buffer 1. 
2.1.3 Study on Growth Properties Mediated by ApoE Isoforms 
2.1.3.1 Reagents for Growth Curve Construction 
1) Hemacytometer 
Cell number was determined by direct cell count using hemacytometoer 
purchased from Sigma (St. Louis, MO, USA). 
2) Microscope 
< -
‘ Cell count was performed under a light microscope from Olympus America 
Inc. (Melville, NY, USA) with a magnification of lOX. 
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2.1.3.2 Reagents for ^H-thymidine Incorporation Assay 
1) [methyl-^H] Thymidine (^H-TdR) 
The stock solution (Amersham Biosciences, Buckinghamshire, UK) at a 
concentration of 2 Ci/mmol was kept at 4 °C. It was freshly diluted with PBS 
to make up the 0.02 Ci/mmol working solution before cell labeling. In cell 
labeling experiment, 50 |j.l/well was added into 24-well plates to make up the 
final concentration of 2 fiCi/mmol. 
2) Trichloroacetic acid (TCA) 
TCA used for fixing cells after radioactivity labeling was purchased from 
ICN BioMedicals Inc. (Irvine, CA, USA). 
3) Liquid Scintillation Cocktail 
The OptiPhase 'HiSafe 2’ liquid scintillation cocktail was purchased from 
Perkin-Elmer, Inc. (Wellesley, MA, USA) and kept in dark at room 
temperature. 
2.1.3.3 Reagents for Flow Cytometry 
1) Propidium Iodide (PI) DNA Staining Solution 
The PI DNA staining solution containing 8 ^ig/ml ribonuclease A (RNase A) 
0 -
‘ (Roche Applied Science, Indianapolis, IN, USA) and 40 fig/ml PI (Sigma, St. 
Louis, MO, USA) was freshly prepared in PBS and kept in dark at 4 °C. 
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2) FACS Flow Shealth Fluid 
The shealth fluid is a ready-to-use balanced electrolyte solution containing 
sodium chloride, potassium chloride, disodium EDTA, sodium fluoride and 
anti-microbial agent, which was purchased from the Becton Dickinson 
International (Franklin Lakes, NJ, USA) and stored at room temperature. 
2.1.4 Study on Signaling Mechanisms Mediated by ApoE Isoforms 
2.1.4.1 RNA Extraction 
1) Diethyl Pyrocarbonate (DEPC) 
DEPC was purchased from Amersham Biosciences (Buckinghamshire, UK). 
2) DEPC-treated Double Distilled Water 
DEPC was added to double distilled water at 1:1000 ratio to give 0.1 % (v/v) 
DEPC water and stirred overnight to disperse the DEPC. Thereafter, the 
solution was autoclaved at 1 2 1 � C for 20 minutes to vaporize the remaining 
DEPC. The DEPC-treated water was stored at room temperature. 
3) TRI Reagent and 1 -bromo-3-chloropropane (BCP) 
They were purchased from Molecular Research Center, Inc. (Cincinnati, OH, 
< • 
‘ USA) and kept in dark in room temperature. 
4) Spectrophotometry Cuvette 
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The UVette® used for RNA concentration measurement was purchased from 
Eppendorf (Hamburg, Germany). 
2.1.4.2 Reagents for Gene Expression Profiles using Commercial Gene Array 
1) GEArray™ Q Series Human MAP Kinase Signaling Pathways Gene 
Arrays 
They were purchased from SuperArray Bioscience Corporation (Frederick, 
MD, USA). 
2) Biotin-16-dUTP 
It was purchased from Roche Applied Science (Indianapolis, IN, USA). 
3) Reverse Transcriptase 
RevertAidTM H Minus M-MuLV Reverse Transcriptase was purchased from 
Fermentas (Hanover, MD, USA). It was supplied at a concentration of 200 
U/|il together with a 5X reaction buffer and stored at - 20 °C in a buffer 
containing 50 mM Tris-HCl (pH 8.3)，0.1 M NaCl, 1 mM EDTA, 5 mM DTT, 
0.1% (v/v) Triton X-100, and 50% (v/v) glycerol. The 5X reaction buffer 
contained 250 mM Tris-HCl (pH 8.3)，250 mM KCl, 20 mM MgCl and 50 
mM DTT. 
4) Ribonuclease Inhibitor 
RNAGuard ribonuclease inhibitor isolated from human placenta was 
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purchased from Amersham Biosciences (Buckinghamshire, UK). It was 
supplied at 30 U/|il and stored at - 20 in a buffer which contains 20 mM 
HEPES-KOH, pH 7.6，50 mM KCl, 5 mM DTT, and 50% (v/v) glycerol. 
5) Sodium Chloride Citric Acid Solution (SSC) (20X) 
It was prepared by dissolving 77 g of citric acid, trisodium salt (0.26 M) 
(Sigma, St. Louis, MO, USA) and 175 g of NaCl (3 M) in 1 liter of double 
distilled water and stored at room temperature. 
6) SDS Solution (20 %) 
It was prepared by dissolving 200 g of SDS (USB, Swampscott, MA, USA) 
in 1 L of double distilled water and stored at room temperature. 
7) Low Stringency Washing Buffer (2X SSC, 1% SDS) 
It was prepared by adding 100 ml of 20X SSC and 50 ml of 20% SDS 
solution in 1 L of double distilled water. 
8) High Stringency Washing Buffer (O.IX SSC, 0.1% SDS) 
It. was prepared by adding 5 ml of 20X SSC and 5 ml of 20% SDS solution in 
� 1 L of double distilled water. 
2.1.4.3 Reagents for Protein Quantification and Western Blot Analysis 
‘ Protein assay kit, buffers and apparatus were the same as mentioned in 
section 2.1.2.5 and 2.1.2.6. 
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1) Primary Antibodies 
Primary antibodies, including extracellular-regulated kinase 1/2 (ERK 1/2) 
and phospho ERK 1/2 (pERKl/2), ERK 5 & pERK 5, mitogen-activated 
protein kinase kinase 1/2 (MEK 1/2) and phospho MEK 1/2 (pMEK 1/2), 
c-Jun and its phosphorylated forms, phospho-c-Jun, c-Myc and its 
phosphorylated form (p-c-Myc) were all purchased from Cell Signaling 
Technology (Beverly, MA, USA). All antibodies were stored as unaliquoted 
stock at -20 °C. 
2) Secondary Antibodies 
Anti-rabbit and anti-mouse IgG, peroxidase-linked species-specific whole 
antibodies were purchased from Cell Signaling Technology (Beverly, MA, 
USA) and Zymed Laboratories, Inc. (San Francisco, CA, USA) respectively. 
2.1.4.4 Reagents for Reverse Transcription Polymerase Chain Reaction 
(RT-PCR) 
1) 01igo(dT)i5 
It was synthesized by Invitrogen, Life Technologies (Carlsbad, CA, USA). 
‘ The lyophilized 01igo(dT)i5 were reconstituted in autoclaved double distilled 
water to a concentration of 100 |LIM and stored at -20 °C. 
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2) Primer Pairs 
The oligonucleotide primers used in PCR were designed on the basis of the 
published sequences of genes and synthesized by Invitrogen, Life 
Technologies (Carlsbad, CA, USA). The primer pairs were handled in the 
same way as mentioned in section 2.1.1.6. 
Table 2.3: Primer sequences for genes. 
Product Tm 
Gene Sequences Nucleotide  
(bp) ( � C ) 
F : 5 ' TGATGACATCAAGAAGGTGG 3 ' 789-808 
GAPDH 118 51 
R : 5 ' CAGCATCAAAGGTGGAGGAA 3 ' 897-916 
O d i n F : 5 ' ATACTTTCTGCATCAGCAGC 3 ' 1059-1078 
- 107 51 
A F : 5 ' ATGGCAAATACTTGAGGTAT 3 ' 1146-1165 
O d i n F : 5 ' AAGAAGCTGGTCTGGCTTGC 3 ' 961-980 
113 51 
D1 R : 5 ' CTGGCTCCTTTCTCTTCGCG 3 ' 1054-1073 
F : 5 ' TCTTGCACTCTGGTGTCTCA 3 ' 430-449 
p21 106 58 
R : 5 ' AGAAATCTGTTAGGCTGGTC 3 ' 516-535 
F : 5 ' TGGACCAAATGCCTGACTCG 3' 392-411 
p27 109 51 
R : 5 ' GCCCTTTTGTTTTGCGAAGA 3' 481-500 
2.1.4.5 Reagents for Real Time PCR 
1) TOPOTA Cloning Kit 
It was purchased from Invitrogen, Life Technologies (Carlsbad, CA, USA). 
2) SYBR Green Reaction Mix 
I 
The iQ SYBR Green Supermix containing iTaq DNA polymerase, dNTP mix, 
MgCh and SYBR Green I was purchased from Bio-Rad Laboratories 
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(Hercules, CA, USA). 
3) PCR Plates 
The 96-well PCR plates and optically clear sealing film were obtained from 
Bio-Rad Laboratories (Hercules, CA, USA). 
4) PCR Machine 
The iQ real-time Thermal cycler was purchased from Bio-Rad Laboratories 
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2,2 Methods 
2.2.1 Construction of ApoE Isoform-encoding Piasmids 
2.2.1.1 Subcloning 
Human apoE3 cDNA, previously cloned into a mammalian expression vector 
pcDNA3.1/Neo, was sub-cloned into another vector, pcDNA3.l/Hygro(+). 
Both piasmids were subjected to restriction digestion by Kpnl and Xbal in IX 
OPA+ buffer at 37 °C overnight. The digested products were resolved in 1 % 
agarose gel electrophoresis and gel purified. The apoE3 cDNA was then 
ligated into the linearized pcDNA3.l/Hygro(+) vector by T4 DNA ligase at 
16 °C overnight. The entire ligation product was used to transform into 
competent Escherichia coli (E. coli) strain DH5a. Briefly, after standing on 
ice for 15 minutes, the mixture was heat shocked at 42 °C for 2 minutes, 
followed by cooling on ice for 2 minutes. The competent cells were then 
allowed for recovery by the addition of 800 p.1 of LB medium and incubating 
at 37 °C for 45 minutes. The competent cells were then collected by 
centrifugation at 6500 rpm for 5 minutes. The cell pellet was resuspended in 
100 1^1 LB medium and spread over a LBA agar plate (50 fxg/ml ampicillin). 
I 
Five colonies were selected and checked by PGR amplification for the apoE 
cDNA with conditions shown in Table 2.4. Cycling conditions comprised an 
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initial denaturation of 5 minutes at 95 followed by 35 cycles with 
denaturation at 95 "C for 45 seconds, annealing at 52 for 30 seconds and 
elongation at 72 °C for 30 seconds. Successful amplification was 
accompanied by the addition of 6 % (v/v) DMSO to the PCR reaction to 
resolve secondary structure associated with the high GC content of the 
template. Positive clones, with PCR product of 430 bp, were allowed for 
overnight culture in LB medium containing 50 |xg/ml ampicillin at 37 °C. 
ApoE3 constructs were harvested by plasmid DNA minipreps kit. The 
plasmids were subjected to sequencing analysis by Tech Dragon Ltd. (Hong 
Kong, China) to ensure no mutation. 
Table 2.4: Components in the PCR amplification of apoE cDNA. 
Volume (pX) 
lOX reaction buffer 2.5 
20 mM dNTP mix 0.5 
10 |iM primer F 0.5 
10 |iM primer R 0.5 
DMSO 1.5 
pcDNA3.1/Hygro-apoE3 0.5 
Autoclaved H2O 18.8 
DNA Taq polymerase 0.2 
Total: 25 
.2.2.1.2 Site-directed Mutagenesis 
The apoE2 and apoE4 cDNA were generated from the apoE3 cDNA template 
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cloned into the pcDNA3. l/Hygro(+) vector by QuikChange site-directed 
mutagenesis kit following the manufacturer's instruction. For each construct, 
50 ng of double-stranded pcDNA3.1/Hygro(+)-apoE3 cDNA was subjected 
to PGR amplification by PfuTurbo DNA polymerase using the specially 
designed primer pairs shown in Table 2.2, which were reverse complementary 
to each other and contained a single point of mutation at the middle. The 
components in the PGR reaction were shown in Table 2.5. The plasmid was 
initially denatured for 30 seconds at 95 °C, followed by 14 cycles of 
30-second denaturation at 95 °C, 1-minute annealing at 52 °C and 14-minute 
final extension at 68 °C. After temperature cycling, the mixture was subjected 
to Dpnl digestion (10 U/reaction) for the removal of parental dam-methylated 
apoE3 cDNA template. The entire digested product was transformed into 
competent E. coli strain DHSa following procedures mentioned in section 
2.2.1.1 and plasmids were purified by plasmid DNA minipreps kit. Overnight 
bacterial culture in LB broth containing 15 % glycerol was prepared for 
long-term storage at - 70 °C. The nucleotide sequences of the apoE2 and 
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Table 2.5: Components in the PGR amplification of QuikChange 
site-directed mutagenesis. 
Volume (|il) 
lOX reaction buffer 5 
dNTP mix 1 
10 |iM primer F 1.25 
10 |LIM primer R 1.25 
DMSO 3 
pcDNA3.1/Hygro-apoE3 0.5 
Autoclaved H2O 37 
pfuTurbo polymerase 1 
Total: 50 
2.2.2 Establishment of ApoE-isoform-expressing Cell Lines 
2.2.2.1 Transfection 
Rat F i l l embryonic fibroblasts were used as the cell model and maintained 
in high-glucose DMEM containing 10 % CS and 100 units/ml penicillin G 
sodium plus 100 |ig/ml streptomycin sulfate. ApoE isoform-expressing cell 
lines were generated by transfecting F i l l fibroblasts with the corresponding 
plasmids in which the apoE cDNA was expressed from the cytomegalovirus 
immediate-early promoter. Control cell lines were generated in parallel by 
� transfecting the parental cells with pcDNA3.1/Hygro(+) alone. Transfection 
was performed with L i p o f e c t a m i n e ™ 2000 reagent following the 
* • r 
, manufacturer's instruction. In brief, 1 x 10 cells/well were cultured in 
24-well plates overnight. For each well of transfection, 0.8 jig of DNA and 2 
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|al of L i p o f e c t a m i n e ™ 2000 reagent were diluted in 50 |il of high-glucose 
DMEM separately and mixed gently. After 5 minutes of incubation at room 
temperature, the diluted DNA and Lipofectamine™ 2000 were mixed 
immediately and allowed to stand at room temperature for 20 minutes. 
Thereafter, growth media in the 24-well plate were aspirated and replaced 
with the Lipofectamine™ 2000-DNA complex. After incubating at 3 7 � C 
incubator for 5 hours, the Lipofectamine-DNA complex was removed and 
replaced with growth media. The cells were then maintained at 37 °C 
incubator overnight. 
2.2.2.2 Generation of Polyclonal Stable Cell Lines 
Cells were passed at 1:10 dilution into a 12-well plate and allowed to grow 
overnight at 3 7 � C . Hygromycin-(400 fig/ml) containing growth media were 
added into wells for selection on the following day. Until 90% confluent, 
cells were harvested with trypsinization and transferred to a 75 cm^ flask. Six 
replica transfections were performed for each isoform as well as the control. 
Cells were kept as frozen stock in freezing media containing 10 % CS and 10 
% DMSO and stored in liquid nitrogen. After 2-week selection period, cells 
> 
were maintained in the same media with reduced hygromycin concentrations 
(100 |a,g/ml). Cells between passages 3 and 15 were used for experimental 
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studies and hygromycin was removed from the growth media one week prior 
to experiments. 
2.2.2.3 Protein Extraction 
Cells (7 X 10^ cells) were cultured in 100 mm culture dishes overnight. After 
incubating in serum free media at 37 °C for 24 hours, cells were harvested 
and media were collected. Cells were washed once with PBS and trypisinized, 
followed by centrifugation at 500 x g for 5 minutes at room temperature. Cell 
pellets were washed with PBS for 1 more time and collected by 
centrifugation. Cell pellets were then resuspended and vortexed vigorously 
with lysis buffer and incubated on ice at -20 for 3 hours. The cell lysates 
were boiled at 95 °C for 10 minutes and then clarified by centrifugation at 
12,000 g for 7 minutes at 4 °C. The resulting supernatants were collected and 
stored at -20 °C until further assay 
2.2.2.4 Concentration of Media 
The collected media were centrifuged at 500 x g for 5 minutes to remove any 
- cell debris. They were then subjected to concentration by Centricon® YM-10 
centrifugal filter devices (Millipore, Billerica, MA, USA) with a molecular 
t • 
1 
weight cutoff at 10 kDa. The sample was centrifuged at 3000 x g for 1 hour at 
4°C. Generally, 4 ml of media were concentrated by 20 fold to about 200 fil. 
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They were stored at - 2 0 � C until further assay. 
2.2.2.5 Quantification of Proteins 
The protein contents of the cell lysate and concentrated media were estimated 
by the DC protein assay kit with BSA as standard. BSA solutions at 0.2 
mg/ml, 0.4 mg/ml, 0.6 mg/ml, 0.8 mg/ml and 1 mg/ml were prepared with 
lysis buffer from 1 mg/ml BSA stock solution by serial dilution. Three 
microliters of protein samples were diluted with 27 of lysis buffer. Diluted 
BSA standards or protein samples (12.5 fil) were mixed with 62.5 jil of 
reagent A', followed by the addition of 500 |il of reagent B in a 1-ml plastic 
-
cuvette. The reaction mixtures were allowed to stand at room temperature in 
the dark for 15 minutes before absorbance at 750 nm was recorded using the 
dye reagent as a blank. Both standards and samples were measured in 
duplicate. The concentrations of the protein samples were determined 
spectrophotometrically by BioPhotometer (Eppendorf, Hamburg, Germany). 
Equal amount (100 jig) of protein samples were subjected to SDS-PAGE 
- analysis. 
2.2.2.6 Detection of ApoE Protein by Western Blot Analysis 
t 
SDS-PAGE was carried out to separate the proteins according to molecular 
weights before Western blot. Table 2.6 shows the composition of the chemical 
1 
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reagents needed for casting 15 % SDS-polyacrylamide gel. Samples 
containing the same amount of protein (100 fag) were mixed with 4X SDS gel 
loading buffer and boiled for 10 minutes before loading onto the 
SDS-polyacrylamide gel with a 5 % stacking gel. Four microliters of 
prestained standards were loaded as molecular weight marker and the gel was 
run under constant voltage of 120 volts for 2 hours. 
Table 2.6: Composition of the SDS-polyacrylamide gel for apoE protein 
detection. 
5 % Stacking Gel 15 % Running Gel 
Reagent 
(5 ml) (5 ml)  
30% Acrylamide Stock 0.825 ml 2.5 ml 
Stacking Gel Buffer 1.25 ml -
Running Gel Buffer - 1.25 ml 
Distilled Water 2.875 ml 1.2 ml 
10 % APS 50 III 50 III 
TEMED 3.3 i^l 3.3 i^l  
After electrophoresis, the stacking gel was removed. The gel was rinsed 
briefly with distilled water to remove SDS that could hinder protein transfer. 
One piece of Hybond ECL membrane, two pieces of 3 MM Whatmann 
chromatography papers (Kent, UK) and two pieces of sponge were 
pre-wetted with double distilled water. They were assembled in the wet 
I • 
blotting apparatus from Bio-Rad Laboratories (Hercules, CA, USA). Air 
bubbles were excluded by rolling a plastic tube across the membrane. The 
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proteins on the gel were then electroblotted onto the Hybond ECL membrane 
at 100 volts for 2 hours. After the transfer, membrane with transferred 
proteins was washed for 5 minutes with washing buffer. The membrane was 
then incubated with blocking buffer with constant shaking for 1 hour at room 
temperature to block the non-specific sites for probing. Meanwhile, the gel 
was stained with Coomassie Blue for 30 minutes and then destained. The 
membrane was incubated with goat anti-human apoE antibody diluted at a 
ratio of 1:50,000 in blocking buffer at 4 °C overnight with the addition of 30 
|ig of whole cell lysate from control cell line for pre-adsorption. After 
blotting with primary antibody, the membrane was briefly rinsed with 
washing buffer and then washed for 15 minutes with three changes of 
washing buffer. After washing, the membrane was incubated with horseradish 
peroxidase-linked secondary antibody in blocking buffer (1:2000 dilution) for 
1 hour at room temperature. Incubation was followed by four washes each 5 
minutes in washing buffer for 20 minutes. After the final round washing, the 
„ membrane was subjected to ECL assay. 
2.2.2.7 Enhanced Chemiluminescent (ECL™) Assay 
1 
Equal- volumes of ECL™ detection reagent 1 was freshly mixed with 
detection reagent 2 and pipetted onto the membrane. For each cm of 
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membrane, 10 \i\ of detection reagent was required. The membrane was 
wrapped with cling wrap so that the surface of the membrane was covered 
with the detection reagent evenly and was allowed to react for 1 minute. 
Excessive reagent was removed by holding the membrane vertically and 
touching the edge of the membrane against tissue paper. The membrane 
covered with cling wrap, with the protein side down, was placed in the film 
cassette in which a sheet of X-ray film was placed inside in advance. The film 
was allowed to expose in dark. Finally, the film was developed and the 
immunoreactive bands could be visualized on the X-ray film. 
2.2.2.8 Quantification of ApoE Protein Level by ELISA 
Expression levels of human apoE isoforms in transfected F i l l fibroblasts 
were quantified by a specific sandwich-type enzyme-linked immunosorbent 
assay (ELISA) system as modified from Yoshida et al. (2001). 
Ninety-six-well immunolon plates were coated with 50 )al of goat 
anti-human apoE polyclonal antibody with a final concentration of 1 |ig/ml 
in coating buffer overnight. The coated plates were washed 3 times with 
washing buffer 2 (200 p-l/well) and blocked with blocking buffer at 4 °C 
> 
overnight. The plates were then washed 3 times with washing buffer 1 (200 
fal/well). Recombinant human apoE3 protein was diluted in PBS to obtain a 
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Standard curve that was linear from 1.25 ng, 2,5 ng, 5 ng，10 ng and 20 ng. 
One hundred micrograms of whole cell lysates or concentrated media 
proteins was diluted with PBS to 100 of PBS then added to wells in 
duplicate and incubated overnight at 4 °C. Plates were washed 3 times with 
washing buffer 1 (200 |il/well) and then incubated with goat 
biotin-conjugated anti-human apoE antibody (100 |il/well) at a 
concentration of 1 |j.g/ml for 1 hour at room temperature. After washing 5 
times with washing buffer 2 (200 }il/well), avidin peroxidase in washing 
buffer 2 (100 jul/well) at a concentration of 2.5 |ag/ml was added and 
incubated for 1 hour at room temperature. The plates were then washed 2 
times with washing buffer 2 (200 pl/well)，followed by 3 times with 
washing buffer 1 (200 ^il/well). After all, 0.001 volume of 30 % H2O2 was 
added to 1 volume of 冲 T S and 100 \x\ was added to each well. The plates 
were wrapped in aluminum foil and color development was allowed to 
proceed for 30 minutes. The plates were at last read on a model 3550 
microplate reader (Bio-Rad, Hercules, CA, USA) at a wavelength of 405 
nm. ApoE levels were calculated by comparison to the standard curve and 
* • 
I 
expressed as ng/)j.g using PBS only as blank. 
1 
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2.2.2.9 Cell Morphology Study 
The cellular morphologies of control non-apoE expressing cells and apoE 
isoform expressing cells were studied by using light microscopy (Olympus 
IX-71, Melville, NY, USA). 
2.2.3 Characterization of Growth Properties of ApoE-isoform-expressing Cells 
2.2.3.1 Cell Proliferation Rates 
-I 
Cells (1x10 cells/well) were plated in 24-well plates overnight and serum 
starved (0.1 % CS) for 48 hours. Quiescent cells were then stimulated by 
serum (10 % CS) to proliferate and cell numbers were determined every 2 
days from day 3 to day 13. Media supplemented with 10 % CS were changed 
every 2 days throughout the course of experiments. At the indicated time 
points, cells were trypsiruzed and detached from the plates, and cell number 
was counted using a hemocytometer. Each experiment was performed in 
quadruplicate set-up. 
2.2.3.2 Measurement of DNA Synthesis 
Cells were plated in 24-well plates at a density of 2x10"^  cells/well overnight t 
and synchronized by incubation for 48 hours in media containing 0.1 % CS. 
After synchronization, serum-stimulated DNA synthesis was performed by 
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incubating cells in 500 |Lil/well media containing 10 % CS with 1 }iCi/ml 
^H-thymidine for 24 hours. At the end of incubation, media were removed 
and cells were washed with 500 i^l/well ice-cold PBS twice. Cells were then 
fixed with 500 |il/well ice-cold 10 % TCA for 1 hour on ice. Cells were 
further washed 2 times with 500 |il/well 10 % TCA to remove unincorporated 
tritiated thymidine. Cells were then lysed with 500 ^il/well 1 % SDS and 400 
|il/well was subjected to radioactive counting by adding 4 ml of scintillation 
cocktail. Each experiment was performed in 6-replicate set-up. 
2.2.3.3 Flow Cytometry Analysis of Cell Cycle Profile 
Cells were plated in 6-well plates at a density of 5 x lO^ cells/well overnight 
and synchronized by incubating in media supplemented with 0.1 % CS for 48 
hours at 37 °C incubator. After serum starvation, the culture media was 
replaced with media —containing 10 % CS for 24 hours. After 
serum-stimulated proliferation, cells were trypsinized, washed with PBS and 
pelleted by centrifugation at 500 x g for 5 minutes at room temperature. Cells 
- were then fixed with ice-cold 70 % ethanol (1 ml/well) at - 2 0 � C overnight. 
For staining, fixed cells were centrifuged at 500 x g for 5 minutes at 4 � C . 
» 
After removal of ethanol, cells were resuspended in 500 of DNA staining 
solution containing 8 |ag/ml RNase A and 40 ^ig/ml PI and incubated for 15 
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minutes at 3 7 � C . Stained cells were analyzed for fluorescence intensity with 
a fluorescence-activated cell sorter (Becton Dickinson FACSort, Franklin 
Lakes, NJ, USA) equipped with an argon laser with emitting wavelength 488 
nm, using the CellQuest software. A minimum of 10,000 events were 
acquired for each determination. The percentages of cells in Go/Gi, S and 
G2/M cell cycle phases were calculated by the WinMDI software, version 2.8 
(J. Trotter; Scripps Research Institute, La Jolla, CA, USA). 
2.2.4 Study on Signaling Mechanisms mediated by ApoE Isoforms 
2.2.4.1 Isolation of Total RNA 
Cells (5 X 10' cells/dish) were cultured in 100 mm culture dishes overnight. 
After synchronization in media containing 0.1 % CS for 48 hours, cells were 
supplemented with growth media containing 10 % CS and allowed to grow 
for 24 hours. At the end of incubation, cells were homogenized by adding 1 
ml of TRI reagent directly to the culture dishes and incubated at room 
temperature for 5 minutes to allow complete dissociation of nucleoprotein 
complexes. Cell lysates were then scraped down and transferred to a 1.5 ml 
* • 
1 
microcentrifuge tube. RNA was extracted by supplementing the homogenate 
with BCP (0.1 ml/ml TRI reagent) followed by vigorous shaking for 15 
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seconds. After incubation at room temperature for 10 minutes, the mixture 
was centrifuged at 12,000 x g for 15 minutes at 4 for phase separation. 
Following centrifugation, RNA was exclusively found in the colorless upper 
aqueous phase whereas DNA and proteins remained in the interphase and 
organic phase respectively. The upper aqueous layer 0.7 ml/ml TRI reagent) 
was collected and transferred to another new 1.5 ml microcentrifuge tube. 
RNA was then precipitated from the aqueous phase by mixing with isopropyl 
alcohol (0.5 ml/ml TRI reagent) and stored at -20 °C overnight. On the 
following day, RNA was pelleted by centrifugation at 12,000 x g for 15 
minutes at 4 After removing the supernatants by aspiration, the RNA 
pellets were washed with 75% ethanol (1 ml/ml TRI reagent) and centrifuged 
at 12,000 X g for 5 minutes at 4 °C. Ethanol was removed and the RNA 
pellets were air-dried for,20 minutes at room temperature. The RNA pellets 
were finally resuspended in 30 of DEPC-treated water. RNA concentration 
was quantified spectrophotometrically by BioPhotometer (Eppendorf, 
Hamburg, Germany) at 260 nm. The purity was estimated by the ratio of 
A260/A280 and only samples with values greater than 1.7 were used for further 
1 
experiments. The integrity of the isolated RNA was checked by gel 
electrophoresis on 1 % agarose gel and two predominant bands of 18S ( � 2 kb) 
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and 28S (~5 kb) ribosomal RNA in a ratio of 1:2 were visualized. 
2.2.4.2 Study of Gene Expression Profile by Commercial Gene Array 
A commercial DNA array specific to human MAPK signaling pathway was 
used as a pilot study to investigate the effects of apoE3 on the expression 
profiles of genes in the MAPK cascade using cell lines previously established 
in our laboratory (Ho et al” 2001). 
1) Probe Synthesis 
According to manufacturer's protocol, 3 fig of total RNA was first reverse 
transcribed to a biotin-labeled probe with biotin-16-dUTP incorporated by 
M-MuLV Reverse Transcriptase. 
2) Hybridization 
The membrane was pre-wetted with double distilled water before 
hybridization. The membrane was then hybridized with the labeled probe at 
60 °C in hybridization solution provided in the kit overnight with continuous 
agitation. The hybridized membrane was washed twice with low stringency 
washing buffer for 20 minutes and then twice with high stringency washing 
buffer for another 20 minutes at 60 °C with continuous agitation. 
3) Detection 
Following manufacturer's protocol, chemiluminescent detection with alkaline 
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phosphatase-conjugated streptavidin and CDP-star substrate was performed at 
room temperature and signals were observed by exposing membranes to 
X-ray film. 
4) Data Analysis 
The exposed film was scanned with the image converted to TIFF format in 
16-bit channel. Raw data was extracted from the scanned images using the 
free software ScanAlyze (http://rana.lbl.gov/EisenSoftware.htm)，and the 
results were interpreted by GEArray Analyzer provided by the manufacturer 
(www. superarray.com). Since each array was spotted with a negative control, 
pUC18, and housekeeping gene, GAPDH, all raw signals were first corrected 
for background with pUC18 and then normalized with the housekeeping gene, 
GAPDH in order to estimate the relative abundance of particular transcripts. 
2.2.4.3 Determination of Activation Status of MAPK and Transcription Factors 
by Western Blot 
Following protocol for the detection of apoE protein, the activity of MAPK 
and transcription factors were examined by western blot. The protocol was 
the same as stated in 2.2.2.7 except the primary and secondary antibodies 
) 
being used at different dilutions in different incubation buffers (Table 2.8). 
For ERK5 and pERK5, the proteins were resolved in 10 % 
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SDS-polyacrylamide gels while for all the other target proteins, 12 % 
SDS-polyacrylamide gels were used. 
The amount of protein was quantified by scanning the density of 
immunodetected bands using Image J software (Research Services Branch, 
National Institute of Mental Health, Bethesda, MD, USA) and the band 
intensity was expressed as a fraction to the control cell lines. 
Table 2.7: Composition of the SDS-polyacrylamide gel for signaling 
studies. 
“ 5 % Stacking G e l R - n i n g Gel(5 ml) 
Reagent 
(5 ml) 10 % 12 % 
30% Acrylamide Stock 0.825 ml 1.67 ml 2 ml 
Stacking Gel Buffer 1.25 ml - -
Running Gel Buffer - 1.25 ml 1.25 ml 
Distilled Water 2.875 ml 2.03 ml 1.7 ml 
10% APS 50 50 III 50 III 
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Table 2.8: Antibodies used for the detection of proteins in the 
MAPK-mediated pathways. 
Molecular 
^ „ Primary Ab Secondary Ab 
Target Protein Source � Weight 
Dilution* Dilution*  
(kPa) 
ERKl/2 Rabbit 1:1000 (5%) 1:2000 (5%) 42/44 
pERKl/2 Mouse 1:250 (5%) 1:1000 (5%) 42/44 
ERK5 Rabbit 1:1000 (5%) 1:2000 (5%) 115 
pERK5 Rabbit 1:250 (5%) 1:1000 (5%) 115 
MEKl/2 Rabbit 1:1000 (5%) 1:2000 (5%) 45 
pMEKl/2 Rabbit 1:500 (1%) 1:1000 (1%) 45 
c-Jun Rabbit 1:1000 (5%) 1:2000 (5%) 43 
p-c-Jun Rabbit 1:500 (1%) 1:1000 (1%) 48 
c-Myc Rabbit 1:500 (1%) 1:1000 (1%) 64-67 
p-c-Myc Rabbit 1:500(1%) 1:1000 (1%) 64-67 
*: the percentage in blankets indicated the amount (w/v) of nonfat dried milk 
in the incubation buffer 
2.2.4.4 Quantification of Gene Expression Level by Real Time Polymerase 
Chain Reaction (PCR) 
Real time PCR was used to study the expression profiles of growth-related 
genes in cell lines expressing apoE isoforms and the control non-apoE 
expressing cells. 
1) Reverse Transcription (RT) 
Total RNA extracts were used as templates for producing cDNA using 
. RevertAid™ H Minus M-MuLV Reverse Transcriptase. RT reactions were 
> 
performed using 5 fig of total cellular RNA per 20 reaction mixture 
following the manufacturer's protocols.. Briefly, template RNA was first 
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mixed with 1 jul of 100 mM oligo(dT)i5 and incubated at 70 °C for 5 minutes 
to denature the RNA. Then, 4 |LI1 of 5X reaction buffer, 2 of lOmM dNTP 
mix, 0.5 fil (15 units) of RNAGuard ribonuclease inhibitor and an appropriate 
amount of DEPC-treated water were added to the mixture to make up a final 
volume of 19.8 i^ il. After a further incubation at 37 for 5 minutes, 0.2 |il of 
M-MuLV reverse transcriptase (200 U/ul) was finally added. The 20 \x\ 
reaction mixture was incubated at 42 °C for 90 minutes for cDNA synthesis, 
followed by 70 for 10 minutes for inactivating the reverse transcriptase 
and then cooled to 4 °C. The resulting cDNA samples were then stored at -20 
°C until further use. 
2) Construction of plasmid DNA Containing the Genes of Interests 
The genes of interest were first amplified using routine PCR protocol 
according to section 2.2.1.1. The amount of DMSO added was replaced with 
autoclaved double distilled water. The PCR products were then resolved by 1 
% agarose gel electrophoresis to confirm only a single, discrete band was 
amplified in each reaction. For each gene of interest, 4 |LI1 of PCR product was 
mixed with 1 |il of salt solution and 1 |al of TOPO vector provided in the 
• TOPO TA cloning kit. The reaction was mixed gently and incubated for 5 
I 
minutes at room temperature. Meanwhile, chemically competent E. coli 
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provided in the kit was thawed on ice. After ligation, 2 |il of the cloning 
reaction was added into the vial of competent cells and mixed gently. The 
reaction mixture was then incubated on ice for 15 minutes. The cells were 
heat-shocked for 30 seconds at 42 °C without shaking and then transferred 
back to ice immediately. For recovery, 250 fil of room temperature SOC 
medium provided in the kit was added and the reaction was incubated at 37 
°C for 1 hour with shaking. Afterwards, 100 |LI1 from each transformation 
mixture was spread over a pre-warmed LBA agar plate (50 |Ag/ml ampicillin) 
and incubated at 37 °C overnight. Five colonies were picked and checked by 
PCR amplification. Positive clones were allowed for overnight culture in LB 
broth containing 50 fxg/ml amplicillin at 37 °C. The plasmid DNA was then 
harvested by minipreps kit. 
3) Melt Curve Analysis of Primer Specificity 
The cDNA template was first diluted 100-fold by adding 1 of stock cDNA 
to 99 fil of autoclaved double distilled water. The reaction mix was prepared 
� according to Table 2.9 in master mixture. Aliquots (25 fil) of the reaction 
mixtures were transferred to the wells of a 96-well thin-wall PCR plates. The 
* • 
plate was sealed with optically clear sealing film and spun briefly. Each plate 
was subjected to a PCR amplification protocol of 95 °C denaturation for 30 
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seconds followed by 40 cycles of 10 seconds at 95 °C, 20 seconds at 48-58 
°C and 20 seconds at 7 2 � C . Melt curve analysis was performed immediately 
after the amplification protocol under the following conditions: 1 minute 
denaturation at 95 °C, 1 minute annealing at 55 °C, 80 cycles of 0.5 °C 
increments (10 seconds each) beginning at 55 °C. 
Table 2.9: Components in the real time PCR amplification reaction. 
Volume (i^ i) 
2 X Supermix 12.5 
10 |LIM primer F 1 
10 p.M primer R 1 
Diluted cDNA template 10 
_  Autoclaved H2O ^  
Total: ^  
4) Real Time PCR Amplification of Target Genes 
Specifically, quantitative real-time PCR was performed in duplicate 
(standards) or triplicate (samples) on 0.1 [x\ of template cDNA per 20 |il 
reaction. Same as melt curve analysis, the cDNA template was first diluted 
100-fold by adding 1 i^l of stock cDNA to 99 )il of autoclaved double 
distilled water. And master mix was prepared according to Table 2.9 but with 
“ one amendment: the diluted cDNA was excluded. Aliquots (15 |il) of master 
> 
mix was pipetted into each well of 96-well thin-wall PCR plates, followed by 
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the addition of 10 of diluted cDNA to give a final reaction volume of 25 \i l 
The plate was sealed with optically clear sealing film and spun briefly. The 
reaction was then amplified using the following PCR parameters: 95 °C for 
30 seconds followed by 40 cycles of 95 °C for 10 seconds, 51 or 58 °C for 20 
seconds, and 7 2 � C for 20 seconds. The increase in fluorescence was 
measured in real time during the extension step for the SYBR Green I assay. 
Melt curve analysis was performed immediately following amplification by 
increasing the temperature in 0.5 °C increments starting at 55 °C for 80 
cycles of 10 seconds each. 
The copy numbers of target gene in each sample were quantified from the 
standard curve generated by amplifying 0.1 ng, 1 ng, 10 ng and 100 ng 
starting plasmids. The copy numbers of GAPDH were also quantified by a 
standard curve amplifying 1 ng, 10 ng and 100 ng starting plasmids. The 
corrected fold change of target gene (i.e. normalized to GAPDH loading) in 
each sample relative to that of control was calculated by dividing the fold 





Chapter 2: Materials & Methods 
2.2.5 Statistical Analysis 
Mann-Whitney rank sum test was performed to detect statistic differences of 
apoE expression levels between two sets of polyclonal cell lines of each 
isoform. Kruskal-Wallis one way analysis of variance (ANOVA) on ranks 
was performed to detect statistic differences among experimental groups. 
Post ANOVA Dunnett's test was used to detect the difference between 
control and apoE isoform-expressing cells while Student-Newman-Keuls 
method was performed for comparison among apoE isoforms. A significance 
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3 Results 
3.1 Construction of ApoE Isoform-encoding Piasmids 
Both the apoE3-containing pcDNA3.1/Neo and pcDNA3.1/Hygro(+) vectors 
were restriction digested by Kpnl and Xbal. The digested products were resolved 
on 1 % agarose gel and purified. The apoE3 cDNA was then cloned into the 
linearized pcDNA3.1/Hygro(+) vector. The apoE3-containing 
pcDNA3.1/Hygro(+) vector was used as the template for constructing the apoE2 
and apoE4 piasmids by site-directed mutagenesis. Automated DNA sequencing 
confirmed that the piasmids harbored the desired mutation points at the 
corresppnding sites, and no other undesired mutations were present. Figure 3.1 A 
shows a T to C mutation in apoE4 construct while Figure 3. IB shows a C to T 
mutation in apoE2 construct at nt 433 and nt 571，respectively. 
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A. B. 
Apo£2： C G T G T G C G G C C G A A G [T] G C C T G G 
ApoE3: C G T G T G C G G C C G A A G C G C C T G & 
fdM, Mi] 
ApoE4： c (J T G M G C G G C C G A A G C G C C T G G 
•麵Mfc 
Figure 3.1. Automated DNA sequencing results of plasmids encoding apoE 
«• 
isoforms. Sequencing results shown are corresponding to nucleotides A) nt 429 -
439 and B) nt 567 - 577 of human apoE cDNA. The underlined nucleotides 
represented the codons encoding for amino acid residues A.) 112 and B.) 158. 
The mutation points generated are boxed. The TGC codon encodes for cysteine 
, while the CGC codon encodes for arginine. 
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3.2 Establishment of ApoE Isoform-expressing Cell Lines 
After preparing the apoE isoform-encoding constructs, they were transfected into 
rat embryonic fibroblasts for studying the effects of apoE isoforms on cell 
proliferation. The apoE cDNA expression was driven by the cytomegalovirus 
(CMV) immediate-early promoter. Control cell lines were established at the same 
time by transfecting with the vector encoding pcDNA3.l/Hygro(+) alone. 
Transfected cells were selected in hygromycin-containing media and expanded 
» 
into stable cell lines. The expression and secretion of apoE proteins were 
confirmed by western blot of whole cell lysates and concentrated media 
respectively. Figure 3.2 shows the immunoblotting results, indicating that apoE 
was synthesized and secreted into the media by the transfected cells. The 
expression levels of apoE were quantified by a sandwich-type ELISA. Table 3.1 
indicates the concentration of apoE present in whole cell lysates and concentrated 
media. In addition, the total amount of apoE proteins was calculated by summing 
up the amount present in cell lysates as well as media. Two sets of polyclonal cell 
lines were used for further assays. Cells in set A showed similar apoE expression 
level while the expression level of apoE4 in cells of set B was significantly lower 
‘ than that of apoE3. In addition, the total apoE expression level of each isoform in 
set B was significantly higher than that of set A. 
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Ctrl E2 E3 E4 





Media H ^ ^ ^ 
Figure 3.2. Immunoblotting of apoE protein. Stably transfected fibroblasts were 
harvested after 24 h incubation in serum free media, followed by extraction of cell 
proteins and concentration of media. Equal amounts (50 fig) of samples were loaded 
onto SDS-15 % polyacrylamide gels. ApoE was detected by immunoblotting with 
polyclonal anti-human apoE antibody and ECL reaction. Results show the expression 
of apoE proteins of two sets of polyclonal cell lines (Set A and Set B). 
» 
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ApoE Concentration (ng/fig cell lysate proteins)  
Control ApoE2 ApoE3 ApoE4 
Cell Lysate 0.000 0.037 ± 0.003 0.041 ±0.006 0.038 ±0.004 
Se tB 0.000 0.108 土 0.026 0.143 ±0.012 0.094 ± 0.019 
—•--. — 一— 
Set A 0.000 0.108 ± 0.027 # 0.105 0.030 # 0.111 ± 0.035 # 
Media 
Se tB 0.000 0.433 土0.039 0.471 ±0.046 0.250 ±0.025 * 
Total ApoE Set A 0.000 0.145 土 0.031 “ 0.146 土 0.034 “ 0.149 土 0.040 ^ 
Protein Se tB 0.000 0.541 ±0.043 0.614 ±0.054 0.344 ± 0.029 * 
Table 3.1. Expression level of apoE proteins as quantified by a 
sandwich-type ELISA. Proteins prepared for western blot were also used for 
ELISA quantification. Equal amounts (50 |ig) of cell protein extracts or media 
proteins were added into each well of ELISA plates coated with anti-human apoE. 
The concentration of apoE proteins was calculated from the standard curve and 
expressed as ng/|ig of protein in cell lysates. Data represents the mean 士 SEM of 
two experiments in duplicate set up. Results show the expression levels of apoE 
proteins of two sets of polyclonal cell lines (Set A and Set B). #: Statistical 
significant difference between the amount of apoE proteins present in media of 
the two sets of cells (p < 0.05). ：^ Statistical significant difference between the 
amount of total apoE proteins (cells plus media) of the two sets of cells (p < 0.05). 
*: Statistical significant difference between the amount of media and total apoE 
proteins in apoE3- and apoE4-expressing cells in Set B. 
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3.2.1 Cell Morphology Study 
Consistent with previous findings (Ho et ai, 2001)，the expression of apoE 
isoforms induced morphological changes in F i l l rat embryonic fibroblasts. 
The apoE isoform-expressing cells were more oval in shape, as compared to 
the spindle shape of the control non-apoE expressing cells (Figure 3.3). 
Nevertheless, no apparent difference was observed among cells expressing 
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A. B. 
C. D. 
Figure 3.3. Cellular morphology of control and apoE isoform-expressing 
cells. The morphology of A) control non-apoE expressing, B) apoE2-, C) 
apoE3- and D) apoE4-expressing cells was observed under light microscopy. 
Expression of apoE isoforms results in more oval shape of rat fibroblasts 
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3.3 Characterization of Growth Properties ofApoE Isoform-expressing Cells 
3.3.1 Cell Proliferation Rates 
In order to determine whether the three apoE isoforms had sustained effect on 
cell proliferation, the proliferation rates of control and apoE 
isoform-expressing cells were compared by constructing growth curves over 
a period of two weeks. ApoE-expressing cells had slower proliferation rates 
during log phase growth than the control cells (Figure 3.4). In both sets of 
cells, the population doubling time (PDT) of apoE3-expressing cells was 
significantly 30 %) longer than that of control cells (Table 3.2). Cells 
expressing apoE2 and apoE4 were also associated with increased PDT 10 
%), but to a lesser extent when compared to apoE3. In addition, the 
expression of apoE isoform did not significantly alter the saturation density of 
rat fibroblasts, as determined by cell counts at the plateau phase of the growth 
curves (Table 3.2). 
» 
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Figure 3.4. Growth curves of control and apoE isoform-expressing cells. Cells 
plated in growth media overnight were synchronized by 0.1 % CS serum starvation 
for 48 h. Quiescent cells were then stimulated by serum (10 % CS) to proliferate on 
day 0 and cell numbers were determined every 2 days from day 3 to day 13. Media 
supplemented with 10 % CS were changed every 2 days throughout the course of 
experiments. At the indicated time points, cells were trypsinized and counted using a 
,hemacytometer. Results show the growth curves of two sets of polyclonal cell lines 
A) Set A arid B) Set B. Each data point represents the mean 土 SEM of an experiment 
in quadraplicate set up. 
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Cell Line 
Control ApoE2 ApoE3 ApoE4 
“ ~5 ^ ^ 
Population Doubling ^^^^ ±1.14 士 1.34 ±1.79 土 0.75  
Time (PDT), h 34.0 38.0 44.9 * 38.1 
SetB +0.47 ±1.22 ±1.26 ±1.98 
106.24 ^ 
Saturation Density ^ 土 5.89 土 5.93 土 2.51 ±6.56  
(X 1,000)，cells/cm^ 106.82 107.11 ^  
SetB ±5.53 ±8.12 土 6.56 ±8.99 
Table 3.2. Population doubling time and saturation density of the polyclonal 
control and apoE isoform-expressing cells. Results represent the mean 土 SEM of 
an experiment in quadruplicate set up. *: Statistical significant difference between 
control and apoE3-expressing cells {p < 0.05). 
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3.3.2 DNA Synthesis 
The inhibitory effects of apoE isoforms on cell growth were further 
confirmed by DNA synthesis studies using ^H-thymidine incorporation. ApoE 
isoform-expressing cells were shown to have decreased ^H-thymidine uptake 
relative to the control cells at the log phase growth (Figure 3.5). Consistent 
with the PDT determined from the growth curves study, apoE3 was 
associated with the most potent anti-proliferative effect with a significant 
decrease in DNA synthesis of ~ 20 % in both apoE3-expressing cell lines. 
The inhibitory effects of apoE2 and apoE4 were less potent, only one of the 
two cell lines reached statistically significant inhibition of - 10 %. 
Nevertheless, there was no significant difference in ^H-thymidine uptake 
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• Set A 
[ 1 2 0 . • SetB 
o 
"I 100 - rj-i * T * 
1 丨 _ 
Control ApoE2 ApoE3 ApoE4 
Figure 3.5. Effects of apoE isoforms on serum-induced DNA synthesis. 
Cells were plated in growth media overnight. After synchronizing in media 
containing 0.1 % CS for 48 h, cells were stimulated to proliferate in media 
containing 10 % CS and 1 fiCi/^il [^H]-thymidine for 24 h. TCA-insoluble 
radioactivity was extracted by 1 % SDS and measured by liquid scintillation 
counting. Two polyclonal cell line sets (Set A and Set B) including control 
- 3 • • 
and each apoE isoform were used for experiments. The H-thymidine uptake 
of control cells was set as 100 %. Data are expressed as mean 士 SEM of five 
independent experiments in six replicates set up. *: Statistical significant 
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3.3.3 Flow Cytometry Analysis of Ceil Cycle Progression 
The effects of apoE isoform expression on cell cycle progression were 
studied by flow cytometry analysis in order to gain insights of the 
mechanisms underlying the anti-proliferative effects of apoE. From the 
distribution of DNA content of the gated cell population shown in Figure 3.6, 
the apoE-expressing cells were found to be associated with significant 
prolongation of GQ/GI phase of the cell cycle. After 24 h serum stimulation, 
less than 30 % of control cells were in Go/Gi phase while ~ 40 % of apoE 
isoform-expressing cells accumulated in this phase of the cell cycle. And this 
was associated with a corresponding significant decrease in cell population in 
the G2/M phase (over 50 % in control cells versus � 4 0 % in apoE 
isoform-expressing cells). Similar effects were found in all three isoforms 
with no significant isoform-specific effects observed. And there was also no 
significant difference between cells of high (Set B) and low (Set A) 
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Figure 3.6. Effects of apoE isoforms on cell cycle progression. Cells were 
plated in growth media overnight. After synchronizing in media containing 
0.1 % CS for 48 h, cells were stimulated to proliferate in media containing 10 
% CS for 24 h. Cells were harvested and subjected to fluorescence-activated 
cell sorter analysis. Total DNA content was quantified in control and apoE 
isoform-expressing cells by measuring propidium iodide staining. Panels A 
and B were data collected from cells in Set A. Panels C and D were data 
collected from cells in Set B. In A & C，the distribution profiles of gated cell 
population according to DNA contents in I) Control, II) ApoE2-, III) ApoE3-， 
and IV) ApoE4-expressing cells are shown. In B & D，the distributions of 
cells in different cell cycle phases were shown in percentage. Results in A and 
C are representatives while data in B & D are expressed as mean 土 SEM of 
two independent experiments in triplicate set up. *: The percentage of cells in 
Go/Gi phase of the cell cycle differed significantly between control and apoE 
isoform-expressing cells {p < 0.05). #: The percentage of cells in G2/M phase 
of the cell cycle differed significantly between control and apoE-isoform 
expressing cells (p < 0.05). 
I 
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3.4 Study on Signaling Mechanisms Mediated by ApoE Isoforms 
3.4.1 Study of Gene Expression Profile by Commercial Gene Array 
Since it has been previously reported that both endogenous and exogenous 
apoE inhibit the activation of MAPK (Ho et ai, 2001; Ishigami et ai, 1998)， 
previously established F i l l rat embryonic fibroblast-derived vector control 
and apoE3-expressing cells were used in a pilot study to investigate the 
effects of apoE3 on the expression profiles of genes in the MAPK signaling 
cascade using G E A r r a y ™ Q Series MAP Kinase Signaling Pathways Gene 
Array. Figure 3.7 shows the array result, with -arrowheads indicating the 
genes whose expressions were differentially regulated by apoE3. Overall, 
apoE3 exerted a suppressive effect on the expression of genes involved in the 
MAPK cascade. Table 3.3 shows a list of the major differentially displayed 
genes in apoE3-expressing cells relative to non-apoE expressing cells. In 
particular, growth related genes such as c-jun and ERK5 were given priority 
for further studies. In addition, the change in expression of cdc42 and Racl, 
which are functionally related to actin cytoskeleton reorganization, was likely 
involved in apoE-induced morophological changes in fibroblasts. 
I 
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Control ApoE3 
Figure 3.7. Differential display of genes involved in MAPK cascade in 
control and apoE3-expressing cells. RNA extracted from control and 
apoE3-expressing cells were used as starting materials. After biotin labeling, 
the cDNA probes were hybridized to the DNA arrays specific to MAPK 
cascade. Following detection using CDP-star substrate, the membranes were 
exposed to X-ray film and results were analyzed using software provided by 
the manufacturer. The arrowheads indicate the genes whose expressions are 
down-regulated upon the expression of apoE3: 1) creb2, 2) cdc42, 3) Grp78, 
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Table 3.3. Effects of apoE3 on the expression profile of genes in the 
MAPK signaling cascade. 
Gene Percentage 
Description (main function) 
Name decrease 
1 creb2 cAMP responsive element binding protein 2 90 
(gene transcription) 
2 cdc42 cell division cycle 42 40 
(participation in GTPase system involved in actin 
cytoskeleton reorganization) 
3 Grp78 78 kDa glucose regulated protein 70 
(immunoregulation) 
4 c-jun c-jun 30 
(component of AP-1 transcription factor) 
5 ERK5 mitogen-activated protein kinase 7 90 
(EGF-mediated growth response) 
6 Mnkl homo sapiens MAP kinase-interacting 80 
serine/threonine kinase 1 
(cap-dependent translation repressor) 
'1 Racl Ras-related C3 botulinum toxin substrate 1 60 
(rho family, participation in controlling cell 
motility) 
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3.4,2 Study of Activation Status of MAPKs and MEKl/2 
The results from DNA arrays further support the involvement of MAPK in 
the signaling pathways mediated by apoE. Thus, the activities of individual 
members in the MAPK cascade were further studied by western blot. 
The inhibitory effect of apoE3 on ERKl/2 MAPK activity was re-confirmed 
in the present study. In addition, the effects of apoE2 and apoE4 on ERKl/2 
activity were also studied. The total protein level of ERKl and ERK2 were 
unaffected by the expression of apoE isoforms (Figure 3.8A & B). However, 
the active phosphorylated form was down-regulated in the presence of apoE 
isoforms. As shown in Figure 3.8C, the kinase activities of ERKl/2 were 
decreased by ^ 50 % in apoE3- and apoE4-expressing cells, more prominent 
than that of apoE2-expressing cells ( ~ 30 %)• 
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A. 
Ctrl E2 E3 E4 
p E R K l / 2 { ^ g C Z Z ^ ^ 
S e t A PERKl 1.00 0.71 0.61 0.69 
a e i A pERK2 1.00 0.82 0.66 0.62 
ERKl/2 
ERKl 1.00 1.11 1.21 1.19 
ERK2 1.00 1.27 1.20 1.29 
p E R K l / 2 ^ S S ^ m 一 一 
q f P pERKl 1.00 0 .69 0.28 0.23 
狄 t « pERK2 1.00 0.70 0.33 0.29 
E R K l / 2 ^ B S B S S S ^ S S S ^ Si!!!!^ 
ERKl 1.00 0.92 0.91 0.84 
ERK2 1.00 0.91 0.93 0.83 
• ERKl 
B. 1-2 • ERK2 C. 1.2 • ERKl 
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Figure 3.8. Effects of apoE isoforms on ERKl/2 MAPK expression and 
activity. Control and apoE-expressing cells were synchronized in 0.1 % CS 
for 48 h, followed by serum-stimulated growth in media containing 10 % CS 
for 24 h. Cells were then harvested and equal amounts (100 |ig) of protein 
extracts were subjected to electrophoresis followed by immunoblotting. ApoE 
isoform expression prevented ERKl /2 activation without affecting the total 
protein levels. A): Immunoblotting results of representatives from two 
independent experiments. B) & C): The total protein level of ERKl /2 and 
� pERKl /2 in control cells was set as one and their relative amount in aooE 
isoform-expressing cells was expressed as fractions of that of control cells. 
The relative protein levels were plotted as mean of two independent 
experiments including data from both set A and set B cells. 
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Since all the three isoforms down-regulated ERKl/2 MAPK, the activity of 
their upstream effectors, MEKl/2, was also investigated to determine whether 
the suppressive effects of apoE isoforms occur upstream at the MAPK kinase 
level. 
The activity of MEKl/2 was fairly similar in both control and apoE-isoform 
expressing cells (Figure 3.9A). By quantifying the amount of MEKl/2 and its 
phosphorylated form, it was found that apoE isoforms did not exert inhibitory 
effects on the expression levels as well as activities of MEKl/2 (Figure 3.9B 
& C ) . -
» 
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A. Ctrl E2 E3 E4 
pMEKi/2 wm mm mm i w 
Set A 1.00 0.66 0.75 0.72 
M E K l / 2 ^ m m a ^ m m m m m 
1.00 1.13 1.00 0.94 
p M E K l / 2 
S e t B 1.00 0.83 0.85 0.79 
M E K l / 2 ^ • ^ " P ^ M i ^ l M I I P 
1.00 0.97 0.91 1.03 
B. C. 
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Figure 3.9. Effects of apoE isoforms on MEKl /2 expression and activity. 
Control and apoE-expressing cells were synchronized in 0.1 % CS for 48 h 
followed by serum-stimulated growth in media containing 10 % CS for 24 h. 
Cells were then harvested and equal amounts (100 ^g) of protein extracts 
were subjected to SDS-PAGE, followed by immunoblotting. A) 
Immunoblotting results of representatives from three independent 
experiments of set A as well as set B. B) & C): The total protein level of 
MEKl /2 and pMEKl /2 in control cells was set as one and their relative 
amount in apoE isoform-expressing cells was expressed as fractions of that of 
control cells. The relative protein levels were plotted as mean 士 SEM of six 
independent experiments including data from set A and set B cells. 
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Apart from ERKl/2 MAPK, another member of the ERK family, ERK5 was 
also the target of the present study. The same as ERKl/2, ERK5 is also 
reported to be responsible for mediating responses related to cell growth. 
The effects of apoE on ERK5 were observed at translational level. The total 
ERK5 protein level was down-regulated in apoE isoform-expressing cells, 
with apoE3 and apoE4 giving more potent inhibition than apoE2 ( � 3 0 %) 
(Figure 3.10A & B). This inactivation was also observed at post-translational 
level; the amount of phosphorylated ERK5 was lower in apoE 
isoform-expressing cells relative to that of control cells. However, only 
apoE4-expressing cells gave statistically significant inhibition of ~ 50 % 
(Figure 3. lOA&C). 
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Figure 3.10. Effects of apoE isoforms on ERK5 MAPK expression and 
activity. Control and apoE-expressing cells were synchronized in 0.1 % CS 
for 48 h, followed by serum-stimulated growth in media containing 10 % CS 
for 24 h. Cells were then harvested and equal amounts (100 fig) of protein 
extracts were subjected to electrophoresis and immunoblot anaylses. A): 
ApoE isoform expression down-regulated ERK5 expression as well as 
activation. Results shown are representatives of three independent 
experiments of set A and set B cells. B) & C): The total protein level of 
ERK5 and pERK5 in control cells was set as one and their relative amount in 
apoE isoform-expressing cells was expressed as the fractions of that of 
control cells. The relative protein levels were plotted as mean 土 SEM of six 
independent experiments combining data from set A and set B cells. The total 
ERK5 protein level in apoE3- and apoE4-expressing cells was significantly 
lower than that of control cells (*, p < 0.05). ApoE4 exerted a significant 
inhibitory effect on the activity o f E R K S (# , /?< 0.05). 
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3.4.3 Study of the Effects of ADOE Isoforms on Transcription Factors 
The expression of apoE isoforms caused down-regulation of ERKl/2 and 
ERK5 MAPK activities. Since c-Myc and c-Jun are the downstream targets 
of ERKl/2 as well as ERK5 and believed to play a role in controlling cell 
proliferation by acting as transcriptional factors, their expression as well as 
phosphorylation status were investigated. 
The results of western blot show that the amount of both total and 
phosphorylated c-Myc was fairly similar in both control and apoE-isoform 
expressing cells (Figure 3.11 A). By quantifying their expression levels, it was 
found that apoE isoforms did not significantly inhibit the expression or 
activities of c-Myc (Figure 3.1 IB & C)，although a trend of inhibition 
indicating that apoE4 may have the most potent effect. 
» 
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A. 
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Figure 3.11. Effects of apoE isoforms on c-Myc expression and activity. 
Control and apoE-expressing cells were synchronized in 0.1 % CS for 48 h, 
followed by serum-stimufated growth in media containing 10 % CS for 24 h. 
Cells were then harvested and equal amounts (200 昭）of protein extracts 
were subjected to electrophoresis followed by immunoblotting. A): 
Representatives of immunoblotting results from three independent 
experiments of set A and set B. B) & C): The total protein level of c-Myc and 
p-c-Myc in control cells was set as one and their relative amount in apoE 
isoform-expressing cells was expressed as fractions of that of control cells. 
The relative protein levels were plotted as mean 土 SEM of six independent 
experiments including pooled data from set A and set B cells. For both total 
and phosphorylated c-Myc, no statistical significant effects of apoE were 
observed. 
102 
Chapter 3: Results 
Different from c-Myc, apoE isoforms exerted differential inhibitory effects on 
the expression c-Jun protein and its activity. From Figure 3.12A & B，it was 
noted that the total c-Jun protein of apoE4-expressing cells was significantly 
lower than that of control ( - 30%). And this decrease in total protein level 
was accompanied with a ~ 50 % down-regulation of phosphorylated c-Jun 
(Figure 3.12A & C). The decrease in the level of phosphorylated c-Jun might 
not only be a consequence of decreased c-Jun level, it might also be due to a 
decrease in kinase activity as the percentage decrease in phosphorylated form 
was greater than that of the total proteins. Both apoE2 and apoE3 were also 
associated with a trend of inhibition on the expression as well as activity of 
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Figure 3.12. Effects of apoE isoforms on c-Jun expression and activity. 
Control and apoE-expressing cells were synchronized in 0.1 % CS for 48 h, 
followed by serum-stimulated growth in media containing 10 % CS for 24 h. 
Cells were then harvested and equal amounts (100 ^ig) of protein extracts 
were subjected to electrophoresis followed by immunoblotting. A): 
Representatives of immunoblotting results from three independent 
experiments of set A and set B. B) & C): The total protein level o fc - Jun and 
p-c-Jun in control cells was set as one and their relative amount in apoE 
isoform-expressing cells was expressed as fractions of that of control cells. 
� The relative protein levels were plotted as mean 土 SEM of six independent 
experiments including pooled data from set A and set B cells. For both total 
and phosphoiylated c-Jun, the expression level in apoE4-expressing cells was 
significantly lower than that of control (* , / ?< 0.05). 
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3.4.4 Real Time PCR Reaction Verification of Primers 
Apart from studying the transactivation activities of transcription factors 
c-Myc and c-Jun, the mRNA levels of some of their downstream target genes, 
including cyclin A, cyclin Dl , p21 and p27, were studied by real time PCR. 
Melt curve analyses were performed to confirm the specificity of the chosen 
primers as well as reveal the presence of primer-dimers. It is essential in 
designing an efficient and specific quantitative PCR assay. The annealing 
temperature was determined from the melt curve profiles. PCR product was 
verified by the presence of a single melting temperature peak representing a 
specific product using the iCycler iQ analysis software (Bio-Rad Laboratories, 
Hercules, CA, USA). Figure 3.13 shows the melt curve profiles at which the 
temperature was chosen for real time PCR. The reason for the chosen 
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Figure 3.13. Melt curve diagrams of PCR products using primers 
designed f o r real t ime P C R . After the templates have been amplified at an 
annealing temperature gradient from 48 °C to 58 °C, the PCR products were 
subjected to melt curve analyses. The graphs shown here represents the melt 
curve profiles from which the temperature was chosen for further 
experiments. A) GAPDH; B) Cyclin A; C) Cyclin D 1 ; D ) p21 and E) p27. 
1 
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3.4.5 Quantification of Gene Expression Level bv Real Time PCR 
In order to evaluate the molecular mechanisms by which apoE isoforms exert 
their anti-proliferative effects, the expression profiles of several cell 
cycle-regulatory genes were examined by real time PCR. 
From the flow cytometry analyses (Figure 3.6)，it was found that apoE 
isoforms lengthened the Go/Gi phase of the cell cycle. Cyclin D1 is the first 
cyclin induced for the progression through cell cycle and the activity of 
cyclinD/CDK complex is greatly affected by CKI from the Cip/Kip families, 
such as p21 and p27. In addition, cyclin A is the cyclin required for cells to 
enter into S phase of the cell cycle. Thus, they were chosen as the targets for 
analyses. 
The mRNA expression of cyclin A was increased in apoE isoform-expressing . 
cells (Figure 3.14A) by 50 - 100 %. Specifically, both apoE4-expressing cell 
lines showed a significant increase in cyclin A mRNA level by 100 %. On the 
contrary, cyclin D1 mRNA expression was down-regulated in apoE 
isoform-expressing cells (Figure 3.14B) by 20 - 50 %. Among the 3 isoforms, 
apoE3 gave the most potent effect. Nevertheless, there was no significant 
difference between different apoE isoforms. 
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For p21, its mRNA was up-regulated upon the expression of apoE isoforms 
(Figure 3.14C) with an isoform preference observed. ApoE3 and apoE4 
increased the expression of p21 gene to a similar extend by 40 — 70 %. The 
increase in apoE3- and apoE4- expressing cells was significantly greater than 
that of apoE2-expressing cells. 
On the other hand, an ambiguous effect was observed in another CKI, p27 
(Figure 3.14D). For apoE2- and apoE4-expressing cells, the mRNA level of 
p27 was decreased by 10 - 50 %. Yet, the effects of apoE3 still remains 
unclear at present; two cell lines showing contradictory results. 
K 
108 
Chapter 3: Results 
A. 2.5 -1 • Set A B. 1.2 1 • Set A 
• 2 � • 数 ^1.0 ft 广 SetB丁 
i i . 5 - 1 5 � - 8 * t * t n 
0 i 
^ 1.0 - "D • 丄 
售 墜 售。.4 I 
t 0.5 • £ • 
^ I 广 I 
0.0 I • 丨 丨 • 丨 I •丨丨圓‘丨 0 . 0 丨 _ 丨 ， _ 丨 ， _ 丨 ， _ 丨 , 
/ / / / � / / 7 7 
C. D. 
2-0 1 • Set A * 1.4 1 • Set A � 
« ° SetB * « 1.2 • S e t B 
0> O) 
1 1-5 1 - 1 I 1-0 § £ r , 
o # “ 丄 丄 O 。 8 工 
卜 llf IE: 1 [ 
‘ � /  / / / / / / 
Figure 3.14. Effects of apoE isoforms on mRNA expression of cell cycle 
regulatory molecules. Control and apoE-expressing cells were synchronized 
in 0.1 % CS for 48 h, followed by serum-stimulated growth in media 
containing 10 % CS for 24 h. Total RNA was then extracted and equal 
amount (5 ^ig) was reverse transcripted. Equal amount of diluted cDNA 
(equivalent to 25 ng RNA) was amplified by real time PCR conditions. The 
presence of apoE isoforms increased mRNA expression of A) cyclin A but 
decreased that of B) cyclin Dl. In addition, opposite effects were observed in 
two CKIs: apoE isoforms stimulated C) p21 but inhibited D) p27 mRNA 
�� expression. Data are expressed as mean ± SEM of two independent 
experiments of triplicate set up. Statistical significant difference between 
control and apoE isoform-expressing cells (p < 0.05). #: Statistical significant 
difference between apoE3- and apoE2- or apoE4-expressing cells (p < 0.05). 
. A: Statistical significant difference between apoE2- and apoE4- expressing 
cells (p < 0.05). 
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4 Discussions 
4.1 Establishment of Stable Cell Lines Expressing ApoE Isoforms 
4.1.1 Rat Embryonic Fibroblasts as Cell Model 
The goal of the present work is to characterize the isoform-specific effects of 
endogenously expressed apoE on serum-stimulated cell proliferation and its 
underlying signaling mechanisms. At the very beginning, it is important to 
choose a suitable cell model. F i l l rat embryonic fibroblast has been adopted 
for the present study. 
The F i l l cell line is an established model for studying growth-related 
signaling mechanisms, such as the role of phosphatidylinositol-3-kinase in 
apoptosis (Dahl et aL, 1998) and the interaction of hyaluronan binding protein 
1 with MAPK after mitogenic stimulation (Majumdar et aL, 2002). In addition, 
the lack of native apoE expression in F i l l cells also contributes to its 
suitability to serve as the cell model in the present study. Although the use of 
SMC would enhance the correlation with vascular diseases, their endogenous 
apoE expression would impose a confounding background to the effects of 
apoE isoform expression. It should also be noted that fibroblasts are derived 
• from the same embryonic origin as SMC, thus, the same progenitor of these 
two cell types raises the relevance of using fibroblasts to the development of 
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atherosclerosis. In fact, SMC in adult vessels under normal condition assume a 
fibroblast-like appearance (Gordon et al” 1990). 
4.1.2 PCR Amplification of ApoE cDNA 
The APOE cDNA is a GC rich template (-70 % GC content), thus, it cannot 
be amplified under standard PCR conditions. Additives have to be employed 
to reduce secondary structure. In the present study, both betaine and DMSO, 
which are reported to be useful for improving the specificity of amplifying 
products from GC rich templates, have been tried (Rees et al, 1992; Varadaraj 
& Skinner, 1994). And the results showed that DMSO was a better additive for 
amplifying a single specific band (data not shown). It should also be noted that 
the percentage of DMSO was dependent on the size of products. The 
minimum amount required to amplify the full length APOE cDNA ( � 1 2 0 0 bp) 
was 6 %, while only 4 % would be sufficient to amplify a fragment of about 
430 bp (data not shown). The longer the PCR products, the higher the 
percentage of DMSO required. However, it is reported that 10 % DMSO can 
already reduce Taq polymerase activity by up to 50 % (Varadaraj & Skinner, 
‘ 1994). Thus, the amount of DMSO added is always kept to the lowest level 
that can generate a specific product. 
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4.1.3 Expression Level of ApoE Isoform Transgenes in F i l l Rat Fibroblasts 
The expression of apoE cDNA was driven by the CMV immediate-early 
promoter. It is one of the most commonly used promoters in eukaryotic 
expression systems for its ability to drive high level of transgene expression in 
nearly all mammalian cells. 
Since the integration of plasmids into the host cell genome is a random 
process, the position where the vectors incorporated and their copy numbers 
are beyond our control. Thus, a total of six polyclonal cell lines were 
generated for each of the control and apoE isoform expressor so as to raise the 
possibility of obtaining cell lines with similar apoE protein expression levels. 
Also, two polyclonal cell lines for control and apoE isoforms were used for 
experiments in order to ensure the phenotypes observed were due to the effects 
of apoE isoforms, rather than artifacts of transfection. In addition, the 
difference between polyclonal and monoclonal cell line is that the former is 
representative of the population behavior of cells, integrating different copies 
of plasmids at different sites of the genome. Thus, the results obtained will less 
likely be confounded by clonal variation. 
I 
From the six polyclonal cell lines established, it was to our surprise to find that 
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the expression level of apoE4 protein was generally lower than that of apoE2 
and apoE3. We have tried our best effort to isolate cell lines showing similar 
apoE expression level but only set A cells completely fulfilled this criterion. 
The expression level of apoE4-expressing cells in set B was significantly 
lower than that of apoE3-expressing cells. In addition, since hygromycin was 
present in the growth medium to apply selection pressure to the transfected 
cells，the expression level of apoE proteins was stable from low passage to 
high passage. 
It is documented that apoE genotypes correlate with serum apoE protein 
concentrations with apoE4 carriers showing the lowest serum apoE levels 
(Kao et al., 1995; Utermann, 1985). The reason behind such low expression 
level of apoE4 is still unclear. It has been reported that the expression of 
transgenes driven by the CMV promoter can be up-regulated by activation of 
JNK MAPK and it is believed that this up-regulation is mediated by the 
increased transcriptional activities of c-Jun and ATF-2 (Bruening et al, 1998). 
In fact, AP-1 and ATF binding sites can be found in the CMV immediate-early 
‘ promoter complex (Sambucetti et al” 1989). 
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In the present study, the expression of apoE isoforms resulted in differential 
inhibition on the activity of the transcription factor, c-Jun, a component of 
AP-1 (Figure 3.12)，with apoE4 giving the most potent effect. Given that 
apoE4 also inhibited ERKl/2 and ERK5, the upstream kinases of c-Jun 
(Figure 1.7)，it is possible that the expression of apoE4 imposes a 
self-inhibitory loop on the activity of CMV promoter and accounts for its 
relatively low expression level. 
Interestingly, AP-1 binding sites can also be fcnind in the human APOE 
promoter (Lahiri, 2004). It has been reported that the induction of AP-1-like 
proteins and their subsequent binding to the AP-1 response element in the 
APOE promoter contributes importantly to enhanced gene expression in a 
macrophage model (Basheeruddin et ai, 1994). Thus, whether the 
self-inhibitory loop of apoE4 suggested in the case of CMV promoter is 
applicable to the human APOE promoter and contributes to the lower serum 
apoE concentration in apoE4 carriers requires further investigation. Such 
knowledge will also provide better understanding between apoE and the risk 
. of AD, which has been correlated to the transcriptional activity of the APOE 
gene (Lahiri, 2004). 
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4.2 Growth Properties Mediated by ApoE Isoforms 
4.2.1 Effects of ApoE Isoforms on Cellular Morphology 
Consistent with our previous findings (Ho et al” 2001), expression of apoE 
isoforms induces alternation of cellular morphology. The exact mechanisms 
underlying such changes are still unclear, but our DNA array results (Figure 
3.7 & Table 3.3) provided possible explanation to this phenomenon. The 
expression of apoE3 imposes a suppressive effect on the expression of cell 
division cycle 42 (cdc42) and Ras-related C3 botulinum toxin substrate 1 
(Racl); whose translational products are reported to play important role in 
regulating the actin cytoskeleton organization in all eukaryotic cells 
(Aspenstrom et al, 2004; Girao et al” 2003). In fact, cdc 42 and Rac 1 belong 
to the Rho GTPases family and are widely studied for its regulation on the 
dynamics of specific actin-dependent cellular process (Aspenstrom et al” 
2004). Thus, members from the Rho GTPase family may be responsible for 
the morphological changes in F i l l cells upon apoE expression. 
On the other hand, it is also worthwhile to note that the transition from 
‘ contractile to proliferative phenotype of vascular SMC involves the ERKl/2 
MAPK cascade and phosphorylation of c-Myc (Schauwienold et al, 2003). 
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Since the activities of ERKl/2 are shown to be down-regulated by apoE 
isoforms in the present study, the change from spindle to oval shape of 
fibroblasts may be an indicator of the cells switching to a less proliferative 
state. 
Apart from affecting morphogenesis, proteins from the Rho GTPase family 
also regulate the ability of cells to migrate. Since apoE has been reported 
previously to inhibit SMC migration (Ishigami et aL, 1998; Swertfeger & Hui, 
2001b) in an isoform-dependent manner (Zeleny et al, 2002), members from 
the Rho GTPases family are actually potential mediators of apoE-induced 
cellular responses. 
4.2.2 Serum as the Stimulator of Cell Proliferation 
Serum is a broad range stimulator of proliferation containing different growth 
factors and is employed in the present study. Nevertheless, since it is a 
secretory protein, apoE from the host organism present in the serum may 
interfere with the result. To tackle this, control cell lines were generated in 
� parallel with apoE expressing cell lines, and the proliferation properties of 
apoE isoform-expressing cells were compared to that of the control cells. Thus, 
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the effects of apoE present in the serum became a controlled variable. 
Although fetal calf serum is more commonly used in cell culture, calf serum 
was employed as the stimulator of cell proliferation in the present experiment. 
Our previous study has demonstrated that endogenous expression of apoE3 
inhibited serum-induced cell proliferation (Ho et al” 2001). The proliferation 
rate of non-transfected F i l l cells increased incrementally in response to 
increases in calf serum from 2.5 to 10 % while that of apoE3-expressing cells 
was much less dependent on serum concentration." Thus, although calf serum 
is reported to have lower nutritional value than fetal calf serum, it is 
I 
speculated that the PDT of apoE isoform-expressing cells would be similar if 
fetal calf serum is used for stimulation instead of calf serum. The use of calf 
serum is more advantageous in terms of cost effectiveness. 
In fact, serum-free medium has been used to replace serum-supplemented 
� medium during the course of study. However, the adaptation of F i l l cells to 
serum-free medium was unsuccessful. The cells could not survive when 
‘ switching from 90 % serum-free medium to 100 %. Because of this, the 
effects of apoE present in serum could not be completely eliminated. 
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4.2.3 Isoform-specific Effects of Endogenous ApoE on Cell Proliferation 
In this study, we examined the effects of stably expressed apoE isoforms on 
cell proliferation. Our data demonstrate that endogenously expressed apoE 
isoforms (a) decrease proliferation rates over an extended period (Figure 3.4 & 
Table 3.2)，(b) inhibit serum-stimulated DNA synthesis (Figure 3.5) and (c) 
lengthen the Go/Gi phase of the cell cycle (Figure 3.6). The apoE proteins 
exert isoform-specific effects on proliferation rate and DNA synthesis, with 
apoE3 being the most potent inhibitor on cell proliferation. 
The binding to proteoglycans, particularly to HSPG, is a prerequisite to reveal 
the biological activities of apoE in lipid metabolism (Mahley, 1988; Mahley & 
Rail, 2000). In addition, this binding capacity of apoE is also correlated to its 
anti-proliferative property (Swertfeger & Hui, 2001b). However, it is reported 
that binding to heparin, including HSPG, does not depend on variability of 
apoE conformatipn; all the three apoE isoforms display similar binding 
affinities to HSPG (Shuvaev et al” 1999). Thus, the isoform-specific 
.. jf 
inhibitory effects of endogenous apoE on cell growth cannot be explained by 
� HSPG binding. Instead, other pathways should be considered to account for 
this isoform preference. 
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4.2.4 Comparison of Effects Mediated by Endogenous and Exogenous ApoE 
Study based on purified exogenous apoE proteins also demonstrated an 
isoform-specific effect of apoE on inhibiting platelet-derived growth factor 
(PDGF)-induced SMC proliferation (Zeleny et al” 2002). Consistent to the 
results of endogenously expressed apoE, apoE3 is the most effective isoform 
in inhibiting proliferation in both studies. Nevertheless, exogenous apoE2 is 
more effective in inhibiting cell proliferation as compared to apoE4 (Zeleny et 
al” 2002), while these two isoforms, when expressed endogenously, have 
similar anti-proliferative capacity as shown in the present study. 
The mechanisms underlying the apoE isoform-specific inhibition of cell 
proliferation are still unclear at the present, these discrepant results exerted by 
exogenous versus endogenous apoE isoforms indicate the complexity of the 
underlying mechanisms. However, several aspects are still worth discussing. 
� The difference in the two studies may be due to the use of different stimulators. 
Serum instead of PDGF is used as the stimulator of cell proliferation in the 
. present study. Serum contains a mixture of mitogens, a more broad-based 
responses may be initiated when compared to PDGF. Thus, different 
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downstream signaling pathways are activated and result in different responses. 
Second, endogenous apoE may target at additional pathways which are not 
accessible to exogenous apoE to inhibit cell growth. ApoE proteins from 
different sources are localized at different subcellular compartments; 
exogenous apoE is detected in endocytic vesicles, whereas endogenous apoE 
is found in the secretory pathway as well as non-secretory compartment (Ho et 
ai, 2000; 2001). The intracellular apoE may thus interact with cytoskeletal 
components and result in change in morphology and alternation in signal 
transduction. 
Moreover, it has been reported that a differential accumulation of apoE 
proteins were found in a number of cell types, with a greater accumulation of 
apoE2 and apoE3 than apoE4 (Ji et ai, 1998). If signaling pathways involving 
the interaction between apoE and cellular proteins are, in part, responsible for 
the isoform-specific effects, the amount of apoE4 available for interaction will 
�� then be relatively lower, even the amount of purified proteins added is the 
same. This may dilute the effects of exogenous apoE4. 
In fact, it has been reported that the effects of apoE depends on the source of 
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proteins used. Purified apoE3 and apoE4 proteins added exogenously have no 
effect on neuritic growth while the lipidated apoE shows isoform-specific 
effects (Nathan et al, 1994). ApoE3 increases neuritic extension but decreases 
branching while apoE4 decreases both branching and extension (Nathan et al” 
1994). In addition, purified apoE3 and apoE4 bind to aggregated P-amyloid 
(Ap) peptide, a hallmark of AD, with similar avidities while the 
lipid-associated apoE3 shows preferential binding to A(3 over apoE4 (LaDu et 
al, 1995). 
4.3 Signaling Mechanisms Mediated by ApoE Isoforms 
The present work focused on the molecular signaling mechanisms that are 
involved in apoE-mediated responses. It is well documented that protein 
phosphorylation plays an indispensable role in signal transduction. In order to 
study the phosphorylation status of cellular proteins, immunoblotting assays were 
conducted. Real time PCR was performed to quantitate genes whose expression 
levels are modulated by apoE, 
� 4 . 3 . 1 Effects of ApoE Isoforms on MAPK Activities 
Responses of cells to extracellular stimuli, such as serum, involve a series of 
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signal transduction events across the cell membrane, through the cytoplasm to 
the nucleus. MAPK cascade is one of the many pathways serving such 
purpose and has received particular attention for its diverse functions in 
regulating many cellular processes (Chang & Karin，2001). In the present 
work, the participation of three MAPKs, ERKl/2 and ERK5, in regulating 
apoE-mediated cell proliferation was investigated. 
4.3.1.1 Effects of ApoE Isoforms on ERKl/2 MAPK 
The inactivation effects of apoE3 on ERKl/2 MAPK have been reported by 
members of our laboratory and elsewhere (Ho et al” 2001; Ishigami et aL, 
1998). This study further confirms the inhibitory effect of apoE3; and shows 
that down-regulated ERKl/2 activities were also associated with apoE2 and 
apoE4 expression (Figure 3.8). Based on the present work, it is worthy to note 
that although apoE isoforms show different potency in inhibiting cell 
proliferation, they act through, at least in part, similar mechanistic pathways. 
� Nevertheless, the trend of inhibition on ERKl/2 MAPK activities was not the 
same as that on cell proliferation. Thus, this pathway cannot fully explain the 
‘ isoform-specific effect of apoE on cell proliferation. 
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In fact, the role of ERKl/2 in the Ras/Raf/MEK/ERK pathway for the control 
of cell proliferation has been well characterized. Ras proteins are 
membrane-localized G proteins (Vermeulen et ai, 2003a) with their cellular 
activities being rapidly activated when quiescent cells are stimulated with 
mitogenic ligands, such as growth factors. They act as molecular switch for 
transducing extracellular stimuli into intracellular signals (Takuwa & Takuwa， 
2001). As discussed below, there is actually another Ras effector system, 
phosphatidylinositol 3-kinase (PI3-kinase) signaling pathway, may contribute 
to the apoE-mediated responses. • 
4.3.1.1.1 Upstream Effectors of ERKl/2 
Since ERKl/2 activities are dependent on MEKl/2 activities, it is of 
interest to determine whether the inactivation of kinase activities by apoE 
isoforms involves the MAPK kinase, MEK. From our result, it was found 
that the activities of MEK were fairly similar in control and apoE 
V isoform-expressing cells (Figure 3.9). Thus, the results indicate that the 
inactivation of apoE on the Ras/Raf/MEK/ERK pathway may be restricted 
. to the MAPK level. 
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4.3.1.1.2 Downstream Effectors of ERKl/2 
After dual phosphorylation on the conserved TXY motif, the activated 
MAPKs either remain in the cytoplasmic compartment to phosphorylate its 
membrane-bound or cytoplasmic substrates, such as or 
translocate into the nucleus to act on transcription factors, such as c-Myc 
and c-Jun, and result in expression of genes involved in cell cycle 
progression (Chang & Karin, 2001; Davis, 1993). Nevertheless, apoE 
isoforms seem not to act through the c-Myc-mediated pathway, as no 
statistically significant inhibition was reached, despite a trend of inhibition 
indicating apoE4 is associated with greater modulatory effect (Figure 3.11). 
On the other hand, c-Jun is shown to be affected at both translational and 
post-translational level, but apoE4, rather than apoE3, was associated with 
the strongest suppressive effect (Figure 3.12). 
Although the results obtained could not explain the differential effects of 
apoE isoforms on cell growth in which apoE3 gave the most potent effect, 
it should be noted that, apart from MAPK, many other pathways also 
� regulate cell proliferation, such as cyclic adenosine monophosphate 
(cAMP)-dependent protein kinase A (Stork & Schmitt，2002)，protein 
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kinase C (Clemens et ai, 1992) and peroxisome proliferator-activated 
receptor (PPAR) (Escher & Wahli，2000). In fact, preliminary data 
indicated that the expression of apoE3 suppresses on the expression of 
PPARp, whose biological function is believed to control cell proliferation 
(data not shown). Thus, the possibility that other pathways are involved in 
mediating the isoform-specific anti-proliferative effects of apoE should be 
explored in the future. 
Apart from c-Myc and c-Jun, c-Fos is another transcription factor under 
ERKl/2 regulation. However, since our previous study demonstrated that 
the mRNA level of c-fos was unaffected by the expression of apoE3 (Ho et 
al” 2001), its protein level and phosphorylation status was not determined 
in the present study. Yet, it remains an open question whether the activities 
of c-Fos are affected by apoE isoforms or not. Although both Jun and Fos 
are component of AP-1 transcription factors, the regulations on their 
phosphorylation are distinct (Abate et al, 1993). 
. 4 . 3 . 1 . 2 Effects of ApoE Isoforms on ERK5 MAPK 
In addition to the involvement of ERKl/2, the present study also demonstrates 
^ 125 
Chapter 4: Discussions 
for the first time that another MAPK, ERK5, is involved in the molecular 
pathway mediating apoE responses. Distinct from ERKl/2, the inhibitory 
effect of apoE begins at the translational level, the total ERK5 protein was 
down-regulated to a significant extent by apoE3 and apoE4. However, it is 
interesting to note that at post-translational level, only apoE4 is associated 
with significant inhibitory effects (Figure 3.10). 
4.3.1.2.1 Upstream Effectors of ERK5 
While ERKl/2 is the most extensively studied MAPK, knowledge on the 
role of ERK5 in mediating cellular responses is limited. Nevertheless, 
growing evidence has been supportive towards its participation in growth 
factor-mediated cell proliferation (Kato et al” 1998; 2000; Pearson & 
Cobb, 2002). 
In response to serum, ERKl/2 and ERK5 are activated. And in particular, 
�� one of the serum components, epidermal growth factor (EGF), is found to 
” ^ 
activate ERKl/2 in Ras-dependent pathway while activation of ERK5 
‘ pathway is independent of Ras (Kato et al” 1998). However, another group 
has demonstrated that ERK5 activity is actually increased by Ras (English 
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et ai, 1998). Although apoE expression does not affect MEKl/2 activities 
as discussed above, the involvement of Ras, the further upstream kinase of 
ERKl/2 and ERK5, in apoE induced cellular responses requires further 
investigation. 
The MAPK kinase responsible for phosphorylating ERK5 is MEK5 
(Diaz-Meco & Moscat, 2001). Although MEK5 was not investigated in the 
present study, it is still worth discussing based on our past findings. It has 
been previously demonstrated that the expression of apoE3 fails to prevent 
serum-stimulated tyrosine phosphorylation in F i l l cells (Ho et ai, 2001), 
and the tyrosine kinase activity of EGF-receptor is required to initiate 
cellular mitogenic responses of ERK5 (Kato et ai, 1998; Ullrich & 
Schlesinger, 1990). These observations indicate that apoE does not 
interfere with the binding of EGF to its receptor and the subsequent 
activation, but rather apoE only affects the downstream signaling pathway 
activated by receptor tyrosine kinases. 
� 4 . 3 . 1 . 2 . 2 Downstream Effectors of ERK5 
Though the expression of c-Jun is regulated by a number of effectors, 
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including ERKl/2 and JNK, ERK5 is reported to be the dominant 
modulator (Marinissen et al., 1999). Since apoE4 exerts the strongest 
inhibitory effect on ERK5, this may explain why the phosphorylation of 
c-Jun is the lowest in apoE4-expressing cells. In addition, it has been 
reported that c-Jun regulates its own expression through a positive 
autoregulatory loop (Angel et al” 1988)，thus, it is consistent to find that 
the total c-Jun protein is also the lowest in apoE4-expressing cells. 
Although this cannot explain the isoform-specific effects of apoE on cell 
proliferation, it is worthwhile to follow up on this novel linkage between 
apoE4 and ERK5 as well as c-Jun. ApoE4 is one of the major risk factors 
for the development of AD (Beffert et aL, 1998; Neve & Robakis，1998). 
Interestingly, ERK5 has been reported to play crucial roles in neuronal 
survival (Cavanaugh, 2004) and c-Jun has been demonstrated to be 
involved in beta-amyloid-induced neuronal apoptosis in AD patients 
(Marcus et aL, 1998; Troy et al” 2001). Thus, the relationship between 
apoE4 and ERK5 or c-Jun may provide insights into the molecular 
� mechanisms explaining the pathological linkage between apoE4 and AD, 
which is still poorly understood. 
• •« 
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In addition, the transcription of ERK5-regulated immediate early genes, 
such as c-jun, is mediated through a specific protein family: the myocyte 
enhancer factor 2 (MEF2) (Kato et al, 1997; 2000). Upon growth factor 
stimulation, ERK5 phosphorylates and activates members from the MEF 
family of transcription factors, thereby inducing MEF2-dependent gene 
expression (Kato et al” 1997; 2000). Thus, it is worthy to find out whether 
the phosphorylation status of MEF2C, the major MEF2 known to regulate 
ERK5-dependent immediate early gene expression, is affected by apoE 
isoforms. This may also provide further evidence for the involvement of 
ERK5/MEF pathway in apoE-mediated responses. 
Apart from MEF2C, c-Myc is also a downstream target of ERK5 (English 
et al” 1998). Alhough the inactivation was not statistic significant (Figure 
3.11C)，the phosphorylation status of c-Myc was the lowest in 
apoE4-expressing cells, corresponding to the greatest inactivation of 
ERK5 (Figure 3.10). While the activity of c-Myc is down-regulated to 
certain extent by apoE4, c-Myc-mediated events are unlikely to be the 
, dominant targets of apoE-mediated signaling pathways, since from our real 
time PCR results, the mRNA levels of c-Myc down-stream targets, 
‘ 129 
Chapter 4: Discussions 
including p27 and cyclin A, did not change correspondingly. 
4.3.2 Effects of ApoE Isoforms on Cell Cycle Regulatory Molecules 
c-Myc and c-Jun are transcription factors regulating a number of genes 
participating in cell cycle progression. The Jun proteins form dimer with 
members from the Fos families and become AP-1 transcription factor (Karin, 
1995; Shaulian & Karin, 2002) while the Myc proteins form dimer with Max 
to become active transcription factors (Vermeulen et ai, 2003b). As discussed 
above, c-Myc and c-Jun showed different responses to serum in 
apoE-expressing cells, their transcriptional activities were followed up by 
monitoring the expression of some of their downstream targets, cyclin A, 
cyclin Dl, p21 and p27. 
4.3.2.1 Effects of ApoE Isoforms on Cyclin Expression 
Expression of cyclin Dl is a prerequiste step for cell transition from the Go to 
Gi phase in the cell cycle (Cocks et al” 1992). Consistent with the flow 
cytometry analysis, cyclin Dl mRNA expression is down-regulated in 
. apoE-expressing cells. And this is consistent with result previously reported by 
Ishigami et al. (1998) that apoE3 inhibits PDGF-induced cyclin Dl mRNA 
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expression. 
Both the Ras/Raf/MEK/ERK and MEK5/ERK5 cascades are reported to 
positively regulate cyclin D1 expression and cell cycle progression (Mulloy et 
al” 2003; Terada et al” 1999). Since the MAPKs, ERKl/2 as well as ERK5, 
are inactivated by the presence of apoE isoforms, the decrease in cyclin D1 
transcription further supports the involvement of these two pathways in 
mediating the anti-proliferative effects of apoE in fibroblasts. And it can also 
be correlated to the isoform-specific effects of apoE on cell proliferation, as 
among the 3 isoforms, the suppressive effect on cyclin D1 mRNA expression 
was the strongest in apoE3-expressing cells. 
On the other hand, it is surprising to find that the mRNA of the S-phase cyclin, 
cyclin A was up-regulated in the presence of apoE isoforms. Kothapalli et al” 
(2004) has reported previously that the protein levels of cyclin A was 
down-regulated in aortic SMC when incubated in growth medium containing 
apoE. Apart from cell-type specific response, however, it should be noted that 
‘ the stability of RNA and protein encoded by the same gene are regulated by 
different mechanisms (Ross, 1997)，thus, it is possible that different effects 
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were observed at different levels. Although the protein level of cyclin A has 
not been investigated in the present study, based on the study by Kothapalli et 
ai, (2004), it is speculated that the increase in mRNA amount is a 
compensatory response to the decreased cyclin A protein level. This 
stabilization on cyclin A mRNA may preserve the capacity of the cells to enter 
S-phase. 
4.3.2.2 Effects of ApoE Isoforms on CKIs Expression 
Apart from the two cyclins, another two cell cycle regulators, p21 and p27, are 
also investigated. However, though members from the Cip/Kip families are 
generally believed to be inhibitors of CDKs and results in cell cycle arrests 
(Koff & Polyak，1995; Xiong et al” 1993)，the expressions of p21 and p27 are 
adversely regulated by apoE isoforms. ApoE up-regulates p21 but 
down-regulates p27 mRNA expression. 
The transcription of p21 is modulated by AP-1 through the tumor suppressor 
protein, p53 (Shaulian & Karin, 2001). It should be noted that amongst the 
‘ AP-1 proteins, c-Jun is unique in its role to positively regulate cell 
proliferation through the suppression of p53 expression and function (Shaulian 
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& Karin，2001，2002). Specifically in a fibroblast model, c-Jun represses p53 
gene transcription as well as decreases its transcriptional activity and thus, 
down-regulates its ability to activate the p21 gene (Schreiber et ai, 1999; 
Shaulian et al” 2000). Since c-Jun is down-regulated by apoE isoforms, 
through the action of p53, the mRNA level of p21 is elevated in apoE 
expressing cells relative to control. Based on the facts that apoE3- and 
apoE4-expressing cells showing similar increase in p21 transcription, and 
c-Jun is significantly down-regulated by apoE4 only, additional pathways 
should be involved in mediating apoE3-induced up-regulation of p21 gene 
transcription. One of the other possible mediators of p21 gene transcription is 
nucleosomal histone (Hirsch & Bonham, 2004). In fact, this pathway has been 
reported to modulate p21 gene expression in a p53 independent fashion 
(Hirsch & Bonham, 2004). 
For another CKI, p27, the effects of apoE isoforms on its transcription are 
�� rather ambiguous. For both apoE2- and apoE4-expressing cells, the mRNA of 
p27 was decreased. However, contradictory result was associated with the two 
. apoE3-expressing cell lines. Although it is immature to draw any correlation 
between p27 transcription and apoE isoforms expression at this stage, 
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something still worth discussing. 
The transcription factor, c-Myc, has been reported to be one of the major 
modulators of p27 gene to repress its transcription (Sears & Nevins, 2002). 
Since c-Myc activity is slightly down-regulated by apoE4, and it would be 
expected that the expression level of p27 to be increased. However, this was 
not the case and thus, c-Myc seems not to be responsible for the regulation of 
p27 transcription in F i l l rat fibroblast. Thus, additional pathways are 
suggested in the regulation of p27 transcription, such as PI3-kinase and protein 
kinase B (Martinez-Gac et ai, 2004). 
Alhough the mRNA level of p27 was originally expected to be increased, the 
findings in apoE2- and apoE4-expressing cells are not paradoxical to the 
anti-proliferative effects of apoE. The fact that CKIs can be found in 
complexes with active cyclin-CDKs (Blain et al, 1997; Soos et ai, 1996) 
� raises the possibility that they may act as positive regulators for cell cycle 
progression. It has been reported in a number of studies that p27 is 
� up-regulated during cell proliferation (Blain et al” 1997; Cheng et al” 1999). 
The CKIs can，in fact, act as assembly and kinase promoting factors in 
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cyclin-CDK complexes (Besson & Yong，2000; Cheng et al” 1999; Hiyama et 
al” 1998). Specifically, p27 is not only required for efficient assembly of 
active cyclinD-CDK4 complexes, but it also increases cyclin D1 protein 
synthesis as well as stability in a fibroblast model (Cheng et aL, 1999). 
Nevertheless, the effects of apoE isoforms on p27 transcription is still at a 
preliminary stage, further experiments are required to confirm such the results. 
4.3.3 Summary of the Signaling Mechanisms Underlying ApoE-mediated 
Responses 
Figure 4.1 shows a summarized diagram of the apoE-mediated signaling 
pathways investigated in the present study. Both the most extensively studied 
and the least understood MAPKs, ERKl/2 and ERK5, are involved in 
apoE-mediated responses. However, since both pathways are not inactivated to 
the greatest extent in apoE3-expressing cells, current knowledge on these 
pathways is not enough to explicate the whole picture behind the 
�� isoform-specific anti-proliferative effects of apoE. However, since both 
MAPKs have been reported to modulate the expression of the Gi cyclin, 
� cyclin Dl , and it was down-regulated to the greatest extent by apoE3 among 
the three apoE isoforms, this can partially explain the isoform-specific 
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inhibitory effect of apoE on cell growth. On the other hand, although no 
dosage-dependent effect of apoE isoform on inhibiting cell growth was 
observed, the inhibition of apoE4 on the activities of ERK5 and c-Jun was 
more potent in cells in Set B than Set A. Thus, it is speculated that apoE would 
exert isoform-specific effects on other cellular responses in a dose-dependent 
manner. 
Although the above findings can partially explain the molecular mechanism 
behind the arrest at Go/Gi phase by the expression of apoE isoforms in F i l l 
fibroblast, the involvement of other pathways in apoE-mediated response 
should be considered since cellular proliferation is such a complex 
phenomenon that is regulated by multiple pathways. 
» 
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Figure 4.1. Summarized diagram of the signaling mechanisms underlying 
the apoE-mediated responses. ApoE expression inhibits the activation of 
ERKl/2 and ERK5 MAPK and their downstream pathways. “乂”： apoE exerts 
its inhibitory effect on the MAPKs and c-Jun transcription factors; "HT": genes 
are up-regulated upon apoE expression; "43.": gene is down-regulated upon 
apoE expression; ‘‘?，’： whether mRNA level of gene is under apoE regulation 
remains unclear. . 
4.3.4 Other Pathways Involved in ApoE-mediated Responses 
4.3.4.1 Synthesis of Nitric Oxide 
It has been reported that the inhibitory effects of apoE on vascular SMC 
, proliferation is mediated through the activation of inducible nitric oxide 
synthase (Ishigami et al” 2000). Nitric oxide synthase is the enzyme involved 
‘ 137 
Chapter 4: Discussions 
in the synthesis of nitric oxide (NO), an important modulator of cellular 
functions, including cell growth inhibition (Dubey, 1994; Moncada et al, 
1991). In fact, an isoform-specific preference to induce NO production has 
been reported (Sacre et al” 2003). Among the three isoforms, apoE3 is the 
most potent inducer on NO synthesis when endothelial cells are exposed to 
exogenous apoE proteins (Sacre et al” 2003). The synthesis of NO has been 
correlated to the activity of the heterodimeric lipid kinase, PI3-kinase in 
several different cell types (Castrillo et al, 2000; Diaz-Guerra et al, 1999; 
Malek et al” 1999). Since Ras is a common upstream effector to both 
PI3-kinase as well as ERKl/2 (Takuwa & 丁akuwa，2001; Vermeulen et al, 
2003a), and it has been reported that NO is capable of inactivating ERKl/2 
(Kubo et al., 1998)，it shows the possibility of the existence of cross-talk 
among PI3-kinase, ERKl/2 and NO. Nevertheless, it is clear that more studies 
are needed to elucidate mechanisms responsible for such cross-talk. 
4.3.4.2 Synthesis of Perlecan 
Apart from NO, the anti-proliferative effects of apoE has also been linked to 
> the synthesis of a specific HSPG, perlecan (Paka et al” 1999). Addition of 
recombinant apoE proteins to the culture media of both rat and human aortic 
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SMC results in increased cellular perlecan mRNA level and secretion of 
perlecan protein into media (Paka et al” 1999). And this stimulation is 
isoform-specific, with apoE3 being the most potent stimulator on perlecan 
synthesis (Paka et ai, 1999). In fact, the stimulatory effect of endogenous 
apoE3 on proteoglycan production has also been reported (Obunike et ai, 
2000). Since perlecan is the major HSPG secreted by vascular cells and has 
been negatively correlated to SMC proliferation (Belknap et al” 1999)，it is 
also possible for it to mediate the anti-proliferative effects of apoE on 
fibroblasts. On the other hand, it should also be -noted that HSPG has been 
shown to inhibit MAPK activation in SMC (Ottlinger et al” 1993). Yet, 
whether perlecan or other HSPG actually participates in the anti-proliferative 
effects of apoE isoforms and the exact mechanisms remain to be determined. 
4.4 Conclusions and Future Prospects 
In summary, major findings of this project include: 
1. All three apoE isoforms exhibit anti-proliferative effect on F i l l rat 
fibroblasts by increasing the population doubling time, reducing DNA 
> synthesis and prolonging the GQ/GI phase of the cell cycle. Specifically, the 
population doubling time of apoE3-expressing cells was significantly longer 
‘ 139 
Chapter 4: Discussions 
than that of apoE2- and apoE4-expressing cells, accompanied with a 
significant decrease in DNA synthesis. 
2. There are at least two distinct signaling pathways involved in apoE-mediated 
responses, including ERKl/2 and ERK5 MAPKs. Expression of apoE 
isoforms inactivated the two MAPK cascades to different extent. ApoE3 and 
apoE4 inhibited ERKl/2 to a greater extent than apoE2 while apoE4 showed 
the strongest suppression on ERK5 activity. 
3. Among the two transcription factors studied, c-Jun activities were inhibited 
by apoE isoforms. Consistent decrease in cyclin D1 and increase in p21 
mRNA levels in apoE isoform-expressing cells were observed. 
4.4.1 Conclusions 
From the above findings, the following conclusions can be drawn: 
1. Endogenously expressed apoE inhibits cell proliferation in an 
isoform-specific manner, with apoE3 being the most potent isoform. 
2. Endogenously expressed apoE inhibits ERKl/2 and ERK5 MAPK in an 
isoform-specific manner. 
_ 3. The isoform-specific inhibition of MAPKs is insufficient to explain the 
isoform-specific effects of apoE on cell proliferation. 
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4.4.2 Future Prospects 
For the study of endogenous apoE isoforms, it is essential to keep the 
expression level of different isoforms fairly similar. Since it is now uncertain 
whether the commonly used promoter in mammalian expression system, CMV, 
has preference over apoE isoform expression, it is worthwhile to try other 
promoters, such as SV 40 or RSV, to test whether the relatively low expression 
level of apoE4 is related to the CMV promoter. 
To further elucidate the mechanism underlying the effects of apoE isoforms, 
apart from continuing the studies on Ras/Raf/MEK/ERK and ERK5/MEF 
pathway, in particular, the involvement of NO as well as perlecan should be 
addressed. 
Furthermore, the greatest inhibition of ERK5 and c-Jun activities by apoE4 
among the three isoforms may provide clues to explicate why the inheritance 
of E4 alleles contributes to higher risk of a number of diseases, such as AD. 
Researches aiming at studying the correlation between apoE4 and disease 
, development may focus on this area. 
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